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ABSTRACT 
Accurate, precise, sensitive and reprod cible experimental protocols 
using high pressure liquid chromatographic assay techniques (HPLC) have 
been developed to study some fundamental factors controlling the trans-
port of solutes across liquid membranes. A simple model, previously 
developed by Rhodes and co-workers, used to describe the kinetics of 
solute transport across liquid membranes was evaluated and some formu-
lation aspects of emulsions for use as liquid membranes were studied. 
The removal of solutes from an external aqueous phase by a liquid 
membrane was found to be influenced by a number of factors including 
initial solute concentration, pH of the external aqueous phase, and 
temperature of the system. As the initial concentration of solute 
increased, the apparent transport rate constants decreased. This was 
observed for both single and multicomponent systems. Increasing the 
pH of the external aqueous phase resulted in reduced transport rate 
constants for salicylic acid. This is in agreement with the pH-
partition theory. An attempt was made to predict the uptake of 
salicylic acid as a function of pH using a Computer Simulation 
Modeling Program. Lack of quantitative agreement between experimental 
and predicted data is attributed to the complexity of the systems and 
insufficiency of the model. Salicylic acid uptake increased as a 
function of temperature in apparent agreement with the Arrhenius 
( 
equation. Si ilar y, t he uptake of phenobarbital by a liquid membrane 
system appeare to obey the Arrhenius relationship until a 11 critical '· 
temperature or temperature range was reached (about 43°C). Above the 
critical temperature, the transport rates of phenobarbital decreased 
as temperature was increased. Increasing the viscosity of the liqu·d 
membrane at the critical temperature did not help to improve transport 
at this temperature range. 
Alterations in the physical properties of liquid membranes resulted 
in changes in the rate of solute uptake. Increasing viscosity and oil/ 
water ratio both resulted in reduced transport rate constants for the 
uptake of solutes. These effects can be readily interpreted using 
classical diffusion theory. Liquid membranes which were frozen and thawed 
were satisfactorily used for drug removal indicating the surprising 
robustness of these systems. 
Studies reported in this thesis indicate that previous use of 
liquid membranes for solute transport does not materially affect their 
further use as sinks. These systems also demonstrated the ability to 
remove simultaneously two solutes from a multicomponent system at rates 
which were of the same magnitude as that measured in one solute systems. 
Method of manufacture and appropriate surfactant blends were detennined 
to be key factors in the development of emulsions for use as liquid 
membranes formulated using only Generally Regarded As Safe components(GRAS). 
Liquid membrane systems prepared by the investigator using only GRAS 
components would need substantial further development work before 
commercialization could be effected; however, they do appear to merit 
additional studies for a number of possible pharmaceutical uses. 
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I. OBJECTIVES 
The recent development of liquid membrane systems has prompted 
studies exploring their usefulness (3-16). These systems, which may 
be either water-in-oil-in-water (w/o/w) or oil-in-water-in-oil (o/w/o) 
type emulsions (10), have been investigated for use in areas such as 
blood oxygenation (3,4), encapsulation of enzymes (5,6), the purifica-
tion of waste water (11-14), the separation of hydrocarbons (2,7,11), 
and the removal of toxic substances from the human body (8,9). An 
area of major interest is the potential use of liquid membrane systems 
in cases of drug overdose (15,16). Studies have demonstrated the 
rapid uptake of phenobarbital and aspirin from either pH 2 or 7 
buffer solutions (15). 
As evidenced by the literature, extensive work has been done in 
the area of liquid membrane application. Although the .effect of some 
of the physical and chemical properties of liquid membrane systems on 
drug transport have been studied (15), only recently has work been 
initiated in the area of development of kinetic models to rationalize 
the transport of solutes across liquid membranes. Yang and Rhodes 
investigated the fonnulation variables of liquid membranes on 
transport (17), while Chilamkurti and Rhodes studied the effect of 
molecular structure on transport across liquid membranes (18). Some 
preliminary work was done by Yang and Rhodes on the effect of electro-
lytes on the transport of water through the liquid membranes (17). 
( 
( 
2 
In their work, Yang and Rhodes were able to detennine the macro 
rate ccnstants (a and e) for the systems studied, but they were unable 
to detennine the micro rate constants. For some systems Chilamkurti 
and Rhodes we~e able to establish micro rate constants (18), while in 
other systems their attempts were unsuccessful. 
Al1 of the work reported by Rhodes and his co-workers concerned 
systems in which the internal aqueous phase of a liquid membrane 
functioned as a sink, capturing solute which crossed the liquid mem-
brane from the external donor phase. There are a 1 imited number of 
reports in the literature on the fonnulation of multiple emulsions 
functioning as reservoirs for drug delivery and the difficulties 
encountered in their development (19-22). The choice of oil and 
emulsifying agents are of particular importance when the stability 
and in vivo use of these emulsions is considered. The nature of the 
internal aqueous phase is another potential source of emulsion 
instability if the proper emulsifying agents and additives are not 
included in the formulation. A delicate balance of all system 
components is required for the successful fonnulation of liquid 
membranes. 
The purpose of this project was to develop a precise and 
reproducible protocol for studying the kinetics of solute transport 
across liquid membranes and to use this p~otocol to study some funda-
mental factors controlling liquid membrane solute transport. This 
project was developed also to evaluate a simple model designed to 
rationalize some aspects of the kinetics of liquid membrane transport 
( 
and to investigate the fonnu1ation of l iquid membranes for possible 
..i!l vivo use for drug uptake and drug delivery. 
3 
( 
( 
II. INTRODUCTION 
Three areas are considered here. The first and second deal with 
the general aspects of the kinetics of drug transport and emulsion 
technology, thereby providing background infonnation for discussions 
of liquid membranes. 
A. Principles of Drug Transport 
1. Transport Processes 
4 
"A membrane transport system is created where there is passage of 
a solute across a membrane" (23). This passage may be active, passive, 
or facilitated. Active transport is a process which requires energy 
to allow movement of a solute against a concentration or activity 
gradient. Facilitated transport makes use of additives(i.e. carrier) 
to improve the rate of solute transport over the rate of transport 
expected from passive diffusion (11,12,14). Most drugs seem to be 
transported by passive diffusion. 
Passive transport, or free diffusion, may be described as the . 
random movement of liquid or solute molecules from a solution of high 
concentration into a pure solvent until equilibrium is reached. The 
driving force in this transport is the concentration gradient (23,24). 
Considering passive transport thennodynamically, this process is 
driven entropically. The system undergoes an overall decrease in 
free energy due to an increase in entropy in accordance with the 
( 
~1llowing equation: 
6G = 6H - T~S + Eµ.dn. , , 
Where: 6G = change in free energy, 
6H = change in enthalpy, 
T =absolute temperature (°K), 
6S = change in entropy, 
Equation (1) 
µ = chemical potential of a component, 
n = component. 
5 
Passive diffusion may be described by Fick 1 s first law (23), which 
states: 
dq/dt = -o A (dc/dx) Equation (2) 
Where: dq/dt = rate of solute transfer (number of moles of solute 
crossing the membrane per unit of time), 
D = diffusion coefficient, 
A = area of membrane available for diffusion, 
dc/dx = concentration gradient/thickness of membrane. 
A number of factors influence the passive diffusion of a drug 
across a membrane. These include the partition coefficient, pKa and 
molecular weight of the drug, and the pH of the medium . 
The partition coefficient, the ratio of distribution of solute 
between two inmiscible liquids, is expressed as follows : 
Equation (3) 
Where c1 and c2 are the equilibrium concentrations of solute in liquid 1 
(nonaqueous) and liquid 2 (aqueous) and k is the partition coefficient. 
The rate of solute transport is directly porportional to its partition 
coefficient for a particular system. 
Most drugs are weak acids or weak bases which exist as both 
ionized and unionized species in solution. The extent of ionization, 
( 
which depends Jn •he pKa of the solute and the pH of the solution . 
may be calcula ted us·ng the Henderson-Hasse lbach equation (24 ) : 
pH= pKa +log (salt;acid ) Equation (4) 
Where: pH = reciprocal log of the hydrogen ion concentration of the 
solution (log 1/ [H+]), 
pKa = dissociation constant of the solute, 
(salt/acid) =molar concentration of ionized species/molar 
concentration of unionized species. 
Since the unionized species has a greater partition coefficient 
than the ionized species, it would be expected that as the fraction 
6 
of unionized solute increases, the rate of solute transport increases. 
Acidic drugs are transported most easily from solutions with a low pH 
since the drug does not ionize to any great extent. As the pH of the 
solution increases, the extent of ionization increases, thereby reducing 
the percent of unionized drug available to transfer across a membrane. 
Conversely, basic drugs are transported best from solutions with a 
high pH. As the pH of the solution increases, the extent of ionization 
decreases and the percent of drug available for transport increases. 
The pH-partition theory as it applies to the absorption of drugs in the 
stomach and small intestines . has been studied in both humans (26) and 
animals (27-30). 
2. Kinetics of Transport 
The amount of solute transported from one compartment to another 
per unit of time, or the rate of solute transfer, may be expressed 
using the specific r.ate constant, k, for that process. A reaction may 
proceed by zero, first, or second order kinetics with k calculated 
accordingly. 
( 
( 
7 
Whereas for zero-order kinetics t e ra t e at wh ich the reaction 
proceeds is independent of solute concentration, the rate of a first-
order reaction is directly proportional to concentration, as expressed 
by the following equation: 
dx/dt = -k C Equation (5) 
Where: dx/dt = rate of transfer, 
k = first-order rate constant, 
C = transferable concentration. 
By rearranging Equation 5 and integrating between time 0 and time t, 
the following equation is obtained: 
log C = log c -t 0 (kt/2.303) Equation (6) 
~~here: co = concentration at time 0, 
ct = concentration at time t, 
k = first-order rate constant, 
t = time. 
By plotting log C against time, a straight line is obtained, the 
slope of which is k. Equation (6) permits the calculation of 
concentration at any time, t, when k is known. 
The effect of temperature on the rate of a reaction may be 
described by the Arrhenius equation (25); 
k =A e-Ea/RT Equation (7) 
Where: k = specific rate constant, 
A = frequency factor (frequency of collisions between 
molecules), 
E = energy of activation (minimum kinetic energy a molecule 
a 
must possess in order to undergo a reaction}, 
( 
( 
R = gas constant (1.987 cal/mole°K or 8. 314 Joule/mole°K), 
T =absolu te temperature (°K). 
8 
By plotting the l og of k against l/T, a straight line with a negativ_ 
slope is obta ~ned wh i ch indicates that with a rise in temperature, 
the rate of a reaction increases. As a general rule, the rate 
of a reaction may increase by a factor of 2-3 with every 10° rise 
in temperature. The slope of the line (Ea/2.303R) may be used 
to calculate the energy of activation (Ea) for the system. Ea 
may be calculated also using the following equation: 
Where: 
log (k 1/k2) = Ea/2.303R [(T2-T1);T1T2J Equation (8) 
k1 =rate constant for reaction at temperature T1 (°K), 
k2 =rate constant for reaction at temperature T2 (°K). 
Most pharmaceutical reactions have an energy of activation 
of 8-20 kcal/mole. 
Although the Arrhenius equation is useful in predicting 
shelf-life from accelerated stability testing, there are 
some situations for which the equation is not valid. The slope 
may change at high temperatures or over long periods of time 
because of physical alterations of a dose form, redistri-
bution and/or evaporation of moisture from a dose form or 
container, secondary degradative pathways, or activation 
of ingredients which will enhance the degradation of a 
product (24). At low temperatures accelerated decomposition 
due to dehydration of the system by freezing or due to con-
tamination by microorganisms may result in a change of slope (25). 
( 
B. Emulsion Technology 
1. Definition of Emulsions 
"An emulsion is a thermodynamically unstabie system 
consisting of at least two immiscible l i qui d phases, one 
which is dispersed as globules in the other liquid phase" (25). 
The two immiscible phases of an emulsion consist of a polar 
liquid such as water and a nonpolar liquid such as oil. 
These systems may be classified according to which phase is 
dispersed or internal in the continuous or external phase. 
If the aqueous phase is dispersed in the oil phase, the 
emulsion is classified as a water-in-oil (w/o) type. Al-
ternatively, in cases where the oil phase is dispersed 
throughout a continuous aqueous phase, the emulsion is an 
oil-in-water (o/w) type. Complex or multiple emulsions may 
b.e formed by dispersing an emulsion in another liquid which 
becomes the final external phase. In this way, a w/o 
emulsion dispersed in an aqueous phase forms a water-in-
oil-in-water (w/o/w) multiple emulsion. If an o/w 
emulsion is dispersed in a oil phase, an oil-in-water-in-
oil (o/w/o) emulsion results. Generally, the particle size 
diameter of the dispersed phase of a two phase emulsion may 
range from 0.01 to 100 µm with the majority of them being 
0.1 to 10 µm. 
9 
( 
2. Consi dera t i on of t he Hydrophilic-Lipoph ilic Balance (HLB) 
Approach to Emulsion Fonnulation 
In order t o render an emulsion stable, another component 
must be added to the mixture of immiscible liquids. Surface-
active agents are e~ployed to stabilize emulsions t hrough 
their ability to act at the interface or at the point where 
the two liquid meet. At the interface, surface-active agents 
are adsorbed and" ... lower the surface free energy associated 
with the dispersed phase making the emulsion energetically 
more stable" (31). Details of the theory of interfacial 
phenomena have been discussed extensively with regard to 
their theoretical and practical aspects in emulsion tech-
nology, and they have been the subject of books and review 
articles in colloid chemistry (32-36). 
Surface-active agents may be classified as anionic, 
cationic, nonionic, and ampholytic. Naturally occurring 
substances such as acacia, sterols, and phospholipids are 
used widely as surface-active agents. In pharmaceutical 
technology frequently employed classes of nonionic surface-
active agents include Spans and Tweens, with Myrjs and 
Bryjs used to a lesser extent. Spans are sorbitan esters; 
Myrjs and Tweens are polyoxyethylene sorbitans. 
10 
( 
( 
Surface-active agents may be classi f ied ~cco rd i ng to 
the ratio of their hydrophilic and lipophi 1 ~c characte r istics. 
In pharmaceutical preparations, this ratio, known as the hydro-
phil ic-1 ipophil ic balance (HLB), is a number between 1 and 18. 
Those materials with HLB values below 9 are considered lipo-
philic in character; whereas those with HLB values above 11 
are hydrophilic. Intermediate substances fall into the range 
of 9 to 11. Those emulsifying agents in the range of 3 to 6 
tend to produce w/o emulsions and those in the range of 8 to 
18 produce o/w emulsions. Since Spans are lipophilic in 
nature, they have low HLB values. By contrast, Tweens and 
Myrjs possess hydrophilic characteristics and therefore have 
high HLB values. 
The HLB approach in emulsion formulation aids in the choice 
of emulsifiers for a particular system. By determining 
the required HLB of the components or combination of com-
ponents in an emulsion and matching it to a single emulsifying 
agent or blend of emulsifying agents with the same HLB, a 
suitable formulation may be developed (31). When a blend of 
emulsifying agents is desired, the ratio of emulsifiers required 
to achieve a particular HLB may be determined by the following 
equation: 
% A = 100 (X-HLBB) I (HLBA - HLB8) Equation (9) 
% B = 100 - % A Equation (lo) 
11 
( 
( 
12 
Where A and B c~e the surface-active agents composing the blend and 
X equals the required HLB. 
An important consideration when ~hoosing a blend of surfactants at 
a required HLB is the chemical type of each emulsifying agent. The 
success of a fonnulation depends upon the fatty acid ester and the 
extent of esterification of the emulsifier (31). Achieving correct 
emulsion type is of great importance in emulsion fonnulation. One 
of the major factors governing emulsion type is the ratio of solubility 
of the surface-active agent in the oil and aqueous phases. In general, 
the phase in which the emulsifying agent is most soluble becomes the 
external phase. An emulsifying agent which readily disperses in the 
oil phase will be expected to produce a w/o emulsion. 
The procedures involved in the use of the HLB approach in emulsion 
fonnulation have been described in detail in The HLB System, A Time-
' 
Saving Guide to Emulsifier Selection by the Atlas Chemical Industries, 
Inc. (31). Further consideration pertaining to the chemistry of 
emulsifying agents and the theories of emulsification have been 
discussed thoroughly by a number of authors (2_5, 32-34). 
3. Preparation of Emulsions 
The details of emulsion preparation must be planned carefully in 
advance of ~he manufacturing process in order to achieve a stable 
product. The components of a phannaceutical emulsion must be selected 
with regard for patient safety and ·for efficiency (33,37). Addition 
order and temperature of the components as well as the manufacturing 
process will detennine the final characteristics of the system (33,38-41). 
( 
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Emulsions may be prepared by either the inversion ,or noninversion 
technique. The noninversion technique involves dissolving the 
emulsifier in the aqueous phase and subsequently adding the oil, 
thereby producing an o/w emulsion. The process may be extended by 
continued addition of oil until an inversion point is reached and the 
emulsion becomes w/o. Another noninversion process involves dissolving 
the emulsifying agent in the oil phase and adding it to the aqueous 
phase with an o/w emulsion resulting. Dispersing the emulsifying 
agent in the oil and then adding the aqueous phase produces a .w/o 
emulsion. Continued addition of water to this system results in an 
inversion and an o/w emulsion (33). 
The emulsification process may be accomplished spontaneously (42), 
by simple stirring~ homogenization, colloid milling, or -ultrasonic 
vibrations (33). In research and small scale production, simple 
stirring or shaking methods are employed frequently. Blenders, 
turbine mixers, mortar and pestles, and closed containers may be used. 
For scale-up operations and in industrial manufacturing, homogenizers 
are used. Adjustments in a formulation are often required in the 
scale-up production of an emulsion. An emulsion made by stirring or 
shaking may be a noticeably different product when made by homogeniza-
tion. Homogenized products usually have a smaller overall particle 
size diameter. The particle size and particle size distribution of an 
emulsion are important in predicting the stability of the system. 
In general, an emulsion with a smaller mean particle size will exhibit 
greater physical stability than those with a larger mean particle size. 
( 
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Both the quality ar.c auantity of the oil and emulsifying agents 
will influence the st abil ity of the final emulsion. The concentra ti on 
and type of emuls i fy; g agent have been shown to have an effect on the 
particle size distr i buti on of an emulsion (43). Pharmaceutical emul-
sions intended for oral and parenteral use must be formulated with 
nontoxic, nonirritating components which are generally regarded as 
safe (GRAS). Mineral oil, soybean oil, many Spans, Tweens, Myrjs, and 
phospholipids are examples of components which may be contained in 
products intended for human use. 
In some instances it may be advantageous to include additional 
agents such as stabilizers, thickening agents, antioxidents, and 
preservatives in a formulation to insure stability of the finished 
product. Thickening agents and stabilizers may have particular im-
portance when the aqueous phase contains ions. The viscosity of an 
emulsion may be regulated by the addition of substances to either the 
internal or external phase. Whereas the addition of a miscible liquid 
to the external phase will decrease the viscosity, the incorporation 
of soluble materials into that phase will increase the viscosity of 
the emulsion. A more viscous emulsion results when the ratio of 
internal to external phase is increased. 
Instability of an emulsion may be observed as creaming, cracking 
or breaking, or phase inversion. Due to the formation of floccules 
i n the dispersed phase, creaming, the separation of an emulsion into 
two phases, occurs. 
by gentle shaking. 
(Equation 11) (32). 
The emulsion may be restored to its original form 
Creaming may be explained using Stokes' law 
( 
\ 
Equati n ( l l) 
Where: v = sedimentation of spherica l particles , 
r = radius of particles, 
p = density of the internal phase, 
p = density of the external phase, 0 
g = acceleration due to gravity, 
n =viscosity of the dispersion medium. 
0 
Since the radius term in the equation is squared, particle size 
has the greatest effect on the rate of creaming. A smaller particle 
15 
size results in a slower rate of creaming. With reference to particle 
size distribution, Stokes' law assumes that the particles are 
spherical and uniform in shape. Deviations from this ideal condition 
affect the creaming of a system. Differences between the density of 
the internal and external phases will influence the rate and direction 
of particle settling. If the density of the internal phase is less 
than that of the external phase, a negative value for velocity is 
obtained. This indicates an upward settling or creaming of the 
particles. A positive velocity suggests a downward settling. If the 
emulsion viscosity is increased, the rate of settling will be 
slower. These aspects concerning Stokes' law are discussed in detail 
by a number of authors (25, 32-36). 
Irreversible separation of an emulsion into two distinct phases is 
referred to as breaking or cracking. Particles of the dispersed phase 
coalesce as a result of destruction of the emulsifier film surrounding 
( 
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these particles (37). Vigorous agitation will not restore the system 
to its fonner state. When an emulsion has cracked, it is no longer 
phannaceutically useful. 
An unstable emulsion may be observed when phase inversion or the 
conversion of a system from one emulsion type to another occurs. 
Factors affecting phase inversion include the phase volume ratio of 
the system, pH, temperature, the emulsifying agents, and the addition 
of other materials to the system. This inversion may render an undesir-
able product in tenns of palatability and drug release rate. 
4. Evaluation of Emulsions 
Emulsions may be evaluated in terms of flow (viscosity), appearance 
(colo_r, phase separation), particle size, and emulsion type. 
In phannaceutical fonnulations the flow of a product is important 
when considered in tenns of administration and storage. It must pour 
easily for oral use, flow freely through tubing or a syringe for 
parenteral use, and spread easily for topical use. These properties 
should not change with time. The flow properties of an emulsion may 
be characterized through viscosity detenninations. Viscosity readings 
may be made using any one of a number of instruments including two 
common ones, the Ostwald and Brookfield viscometers. Becher, in 
Emulsion Theory and Practice (33), explains the uses of the various 
viscometers as well as the theory and detennination procedures for 
surface and interfacial viscosity. 
Detennination of emulsion type may be made by either the phase 
dilution, conductivity, or dye solubility methods (33). The phase 
( 
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dilution method is explained in Section III of this paper. The 
conductivity method is based upon the ability of the external phase 
to conduct an electric current. Whereas the external oil phase of an 
w/o emulsion will not conduct electricity, the external aqueous phase 
of an o/w emulsion will conduct electricity. Considering the dye 
solubility method, a water soluble dye will diffuse through the 
external aqueous phase of an o/w emulsion and color the system. A 
w/o emulsion will not be colored when a water soluble dye is added 
to the system. 
Methods of particle size determination have been investigated and 
reviewed extensively by a number of authors, including (33, 36, 37, 
42, 44-47). Although time consuming, microscopic determination of 
particle size using an ocular micrometer is a reliable method. 
Photomicroscopy offers the advantage of obtaining a permanent record. 
Other techniques employed in particle size analysis -of emulsions 
include sedimentation, light scattering and transmi ssion (33,44,45) 
and the use of the Coulter Counter (44,45,47,48). 
The use of accelerated aging studies and factors designed to 
impose a stress on an emulsion have been considered extensively with 
regard to stability (33,36,37,49-54). The use of heat, cyclic 
temperatures, freezing/thawing (37,46), centrifugation (46), and the 
addition of differing quantities of various electrolytes (36,54) have 
all been studied to determine their effects on the stability of 
emulsions. Heat and cyclic temperature treatments impose some of the 
greatest stress on an emulsion system. 
( 
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5. Pharmaceutical Uses of Emulsions 
Emulsions find uses in a number of different areas including the 
paint, agricultural, food, and pharmaceutical industries. Emulsions 
used pharmaceutically may be administered orally, topically, or 
parenterally. Topically applied emulsions in the form of creams or 
lotions serve as vehicles for medicaments or as cosmetic bases. 
Parenteral lipid emulsions are used in long term total parenteral 
nutrition (TPN) therapy. Orally administered emulsions are used to 
improve the palatability of oily bases for medicaments, for nutritional 
purposes such as dietary sources of fats, or to administer fat soluble 
vitamins. Other oral emulsions are used as laxatives or as radioopaque 
agents for diagnostic purposes. An area of recent interest is the oral 
use of multiple emulsions in pharmaceutics for both drug delivery and 
drug uptake (15-18). These emulsion systems are referred to as liquid 
membranes. 
C. Liquid Membranes 
1. Definition and Overview 
Liquid membranes, formed by the dispersion of a two-phased 
emulsion in a third continuous l iquid phase, were developed by Li at 
Exxon Research and Engineering Company in 1968 (1,2). In these complex 
emu l si on systems, the encapsulated or internal phase and the continuous 
external phase are miscible, but they are separated by a thin liquid 
film which is miscible with neither of these phases (14). This liquid 
film is the liquid membrane. 
( 
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There are two major types of liquid membrane systems. A water-in-
oil-in-water (w/o/w) system is formed by dispersing a w/o emulsion in 
a continuous aqueous phase. The dispersion of an o/w emulsion in an 
oil yields an oil-in-water-in-oil (ri/w/o) liquid membrane system. 
W/0/W systems have received more attention in terms of the ·ir potential 
applications, especially in pharmaceutics. When an emulsion is 
dispersed by agitation in a continuous phase, it breaks up into stable 
globule usually 0.2 to 2 mm in diameter. Each globule encapsulates 
aqueous phase droplets of 1 to ~O ~m in diameter. The formulation of 
the primary emulsion is important to the overall stability of the liquid 
membrane system (19-21,55). 
Considering the fo.rmulation of a w/o/w system, a w/o emulsion is 
formulated with the proper specifications. The internal aqueous phase 
may function as a sink to receive materials from the external aqueous 
phase or as a reservoir to release a substance into the external 
aqueous phase. The composition of the internal aqueous phase depends 
upon which of these functions it will assume. In either case the nature 
of the phase wil1 contribute to the challenge of preparing a stable 
emulsion. In the selection of the oil phase the intended purpose of 
the emulsion must be considered. If the emulsion is for oral or 
parenteral use, the oil must fall with the GRAS specifications. 
In order to maintain the overall .stability of the liquid membrane 
system, surfactants, stabilizers, and .viscosity-inducing agents may be 
added· to either the primary em~lsion or the continuous phase of the 
system. The size· of the . dispersed. globules formed depends on the 
( 
20 
nature and concentration of the surfactants in the emulsion as well as 
on the viscosity and method of mixing (14). This, in turn, will 
detennine the surface area available for the transport of solute 
either into or out of the internal aqueous phase. Additives to 
enhance the solubility and penneation rates of solutes through 
facilitated transport (1_1,12) may be incorporated into the fonnulation 
also. Formulation factors pertaining to liquid membrane systems have 
been investigated in both the chemical (2,13,14) and phannaceutical 
industries (17). 
2. Basic Separation Mechanisms Used with Liquid Membranes 
Separation mechanisms as they apply to liquid membranes have been 
discussed by Frankenfeld, Cahn, and Li' (14) and are described below. 
a. Selective Penneation 
This simple mechanism, which was described by Li in reference to 
the separation of hydrocarbons (2), is dependent only upon the selec-
tivity of the liquid membrane to allow specific materials to pass 
through it. 
b. Chemical Reaction Inside Droplet 
This mechanism is based upon the diffusion of an unionized species 
with significant oil solubility (2) from an area of high concentration 
(external aqueous phase) through the liquid membrane and into the 
internal aqueous phase which contains a trapping agent. This process 
has been described by Matulevicius and Li (11) as a type of facilita-
ted transport through maximization of t he concentration gradient. The 
unionized species, through a chemical reaction with the contents of 
I 
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the internal phase, is convert ed to its ionized fonn, a form which 
· does not readi ly transport, and is tr~pped within the internal phase. 
The concentration of transportable species is maintained at zero, 
thus creatjng a favorable concentration gradient. Acidic materials may 
be trapped by an encapsulated aqueous base. Conversely, a basic 
solute may be trapped by an encapsulated aqueous acid. Substances 
such as phenol (12), and phenobarbital and acetylsalicylic acid (15,16) 
have been trapped by this method. 
The removal of a1TU11onia from waste water is a classic example used 
to illustrate this separation mechanism as depicted in Figure 1. 
Awmonia (NH3), in a pH 9 external aqueous phase, exists predominantly 
in its unionized, lipophilic fonn. This species easily transfers from 
the external aqueous phase, through the liquid membrane, and into the 
internal aqueous acid phase where upon contact it is ionized to an oil 
insoluble ammonium ion (NH4+) (13). 
In addition to acidic or basic solutions, plasma proteins, 
activated charcoal, and specific antibodies have been proposed as 
possible trapping agents. 
c. Carrier in Membrane Phase or Facilitated Transport 
In the previous example, the oil solubility of the solute was an 
important factor in its transport through the l i quid membrane. In 
order to assist in the transport of a solute through a liquid membrane 
by improving its solubility in the oil phase, a carrier may be used. 
The carrier, which is incorporated into the external aqueous phase, 
reversi bly binds with the solute to fonn a complex capable of 
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diffusing through the liquid membrane. Once inside the internal 
aqueous phase, a "stripping" agent removes the solute from the carrier. 
Used in the transport of heavy metal ions (i.e. Hg+2, Cr+6, Cd+a, 
Cu+2) (13,14), this method is limited by the extent of suitable 
carriers (14). Carriers must be soluble in the membrane and 
compatible with the surfactants in a system (11). 
d. Adsorption of Water-Insoluble Particles on Membrane Surface 
Absence of reports in the literature suggest that little work has 
been done in the area of adsorption of water-insoluble particles on 
the membrane surface as a mechanism .for achieving separation (14) . 
3. Applications of Liquid Membranes 
a. General Applications 
Since the initial development of liquid membranes, they have been 
tested for a number of potential uses. In the area of waste water 
purification, liquid membranes have been studied with regard to their 
ability to reduce and separate nitrates and nitrites by encapsulated 
enzymes (6,13), the extraction of heavy metals from waste water 
(11,13,14), and the separation of phenols from waste water (12). 
Liquid membranes are capable of separating hydrocarbons (2,7,11) 
and have exhibited promise as a potential way of oxygenating blood by 
a less traumatic, more efficient means (3,4). Research has been 
directed toward developing a liquid membrane which will serve as an 
adjunct to kidney dialysis through the removal of uremic toxins (8,9). 
Enzyme encapsulation by liquid membranes as a means of protecting 
enzymes from destructive materials or to immobilize them also appear 
feasibie (5,6,10). Liquid membranes have also been proposed for 
use in the pharmaceutical industry. 
b. Pharmaceutical Applications 
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At the present time, reported studies in the literature pertaining 
to the use of liquid membranes in pharmaceutics are sparse. Liquid 
membranes have been proposed for use as sinks to trap drugs in the 
treatment of emergency drug overdose (15,16) and for .i.!! vivo drug 
delivery systems (19-21,55). The effect of formulation variables and 
molecular structure on the transport of drugs across liquid membranes 
also have been investigated (17,18). 
The major emphasis of the work involving the use of liquid 
membranes as recipient sinks describes their proposed use in the 
emergency treatment of drug overdose (15,16). Liquid membranes possess 
several distinct advantages over the usual methods of treating drug 
overdose. 
The liquid membranes may be administered easily and in a single 
dose. Since they have the consistency and appearance of a milk shake 
and may be flavored, minimal patient resistance would be anticipated 
(iO). Using a stomach tube, the system may be administered even if 
the patient is unconscious (15). 
The drug classes investigated in the emergency treatment of drug 
overdose were barbiturates and salicylates. Both of these classes have 
a high potential for being present in a drug overdose situation since 
both are easily accessible. Barbituric acid and its derivatives 
account for an estimated ten percent of poisoning deaths per year in 
( 
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the United States with approximate1~ 15 percent of these deaths as 
suicides (56). Although the use of child-proof safety caps on aspirin 
containers has resulted in a decrease in aspirin poisoning deaths in 
children, accidental ingestion of this drug still occurs. This 
accounts for approximately 1.5 percent of the total acc·idental deaths 
due to drugs and medications in children five years of age and 
younger (56). At the present time there are no reports in the litera-
ture pertaining to the emergency treatment of drug overdose with 
liquid membranes and other classes of drugs. 
The results of the in vitro work to evaluate the potential 
usefulness of liquid membranes for the rapid removal of drug from the 
gastrointestinal tract showed that 95% of the phenobarbital present 
in the external aqueous phase was removed within 5 minutes and 
essentially complete removal occurred in 10 minutes. The rate of 
acetylsalicylic acid uptake was slightly faster. The rate of uptake 
followed first order kinetics (16). 
The rate of drug uptake by liqu i d membranes was observed to be 
influenced by variables introduced into the system. The viscosity of 
the liquid membrane proved to be a very important variable. As the 
viscosi~y of the membrane decreased, the rate of drug removal in-
creased at the expense of the membrane integrity. Membranes composed 
of lower viscosity oil phases ruptured and leaked. It was observed 
that at higher temperatures the rate of uptake increased (16), and 
increasing the pH of the external aqueous phase slowed the rate but 
did not affect the completeness of drug removal (15). The presence 
of bile salts in the external aqueous phase had an adverse effect on 
( 
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drug removal (:~) ,and t he ratio of liquid membra ne to external aqueO'!S 
phase was no+ea as an important variable infl uencing the rate of drug 
transport (16) . 
As previousl y entioned, the manufacture of a stable liquid 
membrane is a cnal 1enging task. This is especially true for those 
liquid membrane systems proposed for use in pharmaceutics. For 
example, buffer solution trapping agents add electrolytes to this 
sensitive system which may be a source of instability (20). In order 
to insure a stable emulsion which will function as a liquid membrane, 
an optimum ratio of oil to surfactant must be determined. For 
phannaceutical use, both of these components must be regarded as 
safe (GRAS). 
More extensive studies on the effect of formulation variables on 
the transport of solutes across liquid membranes were conducted by 
Yang and Rhodes (17). Using acetylsalicylic acid and phenobarbital 
as model drugs, they evaluated the effect of liquid membrane oil to 
water ratio, the size the internal aqueous phase droplets, liquid 
membrane viscosity, and internal aqueous phase pH on solute transport. 
Confinning the results of earlier work, they found that the lower the 
membrane viscosity, the faster the rate of drug removal. Faster drug 
removal was observed also with membranes having smaller internal phase 
droplets. Increasing the pH of the internal aqueous phase resulted in 
more efficientacetyl salicylic acid removal from the external aqueous 
phase. 
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Formulation variables have been considered by other investigators 
in attempts to formulate systems suitable for drug delivery. In 
general, it is agreed that the concentration and nature of the sur-
factants (20,21,55), the incorporation of other addit i ves into the 
formulation (19), and the composition of the internal aqueous phase 
greatly influence the successful manufacture of the finished product. 
The effect of molecular structure on the transport of solutes 
across liquid membranes was investigated by Chilamkurti and Rhodes (18). 
The authors were able to reiate differences in rates of solute trans-
port to molecular structure, to show that some ionic species are 
capable of transporting across the membrane, and to demonstrate the 
effect of solute ionization on transport. 
The development of a two compartment kinetic model to rationalize 
the transport of solute from an external aqueous phase across a liquid 
membrane to an internal aqueous phase resulted from the work by Yang 
and Rhodes ( 17). The following equation describes the model 
k12 k23 (12) Ce CLM c. Equation 
k21 k32 
, 
Where: Ce = concentration of solute in external aqueous phase, 
CLM = concentration of solute in liquid membrane, 
c. , ;: concentration of solute in internal aqueous phase, 
k12 ,k21 ,k23 ,k32 = first order micro rate constants. 
Figure 2 depicts the scheme of transport using Equation (12). 
The concentration of drug in the external aqueous phase at any 
time, t, may be determined by the fo l lowing equation: 
.. 
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Fig. 2 Kinetic Model Developed to Rationalize Transport of Solutes 
( 
Where: 
ct =A e- ~t + B e- et +cs tq~ation (13 ) 
e e 
Ct = concentra t ion of solute in the external aqueous phase 
e 
at any time, t, 
A and B = pre-exponential tenns contai ning the micro rate 
constants, 
a and e = first order (macro) rate constants, 
t = time, 
c! = concentration of solute in the external aqueous phase 
at steady state. 
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Although Yang and Rhodes were not able to determine the micro-rate 
constants for the solute uptake process, Chilamkurti and Rhodes (18) 
were able, at least for some systems, to determine these rate constants. 
For salicylic acid, they detennined the uptake process to be mono-
exponential, that is, having a single rate expression, since they 
found k12 is larger than k21 , k23 , and k32 . They found that acetyl-
salicylic acid uptake is biexponential since they determined k12 is 
smaller than both k21 and k23 . In this case both the a and e rate 
constants were observed. It is possible that the application of a 
more sensitive assay technique (i.e. high pressure liquid chromato-
graphy) may serve to define these processes more fully. 
( 
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III. METHOD 
A. Materials 
1. Chemicals 
Acetic Acid, Glacial Reagent A.C.S. (lot # 705283, 
lot # 712081) 1 
Acetonitrile (lot # 121602) 2 
Acetylsalicylic Acid (lot# KC040577) 3 
Aluminum Monostearate 
Boric Acid, crystal (lot # C0075) 4 
Cetyl Alcohol N.F. (lot# Bll030023) 5 
Hydrochloric Acid (lot # KMBV) 6 
Methanol HPLC Grade (lot # UN1230) 1 
Methanol (lot # AH749) 7 
Methylcellulose U.S.P. (lot # C706594)8 
1Fisher Scientific Company, Fairlawn, New Jersey . 
2waters Associates, Milford, Massachusetts. 
3Aldri ch Chemical Company, Inc., Milwaukee, Wisconsin. 
4Allied Chemical, Morristown, New Jersey. 
5Ruger Chemical Company, Inc., Irvington, New Jersey. 
6Mallinckrodt Chemical Works, New York, New York. 
7Burdick & Johnson Laboratories, Inc., Muskegon, Michigan. 
8Amend Drug and Chemical Company, Irvington, New Jersey . 
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Mineral Oil U.S.P. (lot # 119-12) 1 -
Myrj *52 (lot # 260) 2 
Phenobarbital U.S.P. powder (lot # 6588, control MPY) 3 
Phosphoric Acid (lot # YLP) 3 
Potassium Chloride U.S.P. powder (lot # 950373) 4 
Potassium Biphthalate 
Potassium Phosphate Monobasic, crystal (lot # TPJ) 3 
Salicylic Acid (lot# DC 041987) 5 
Sodium Hydroxide U.S.P. pellets (lot# C6222425) 6 
Span **60 (lot # 65576) 7 
Span 80, sorbitan monooleate (lot # 1477) 7 
Tween ***60 (lat# 1153) 7 
Tween 80, polysorbate 80, U.S.P. (lot # 1580) 2 
*Myrj: poloxyethylene ester 
**Span: sorbitan ester 
***Tween: polyoxyethylene sorbitan 
1Pennsylvania Refining Company, Butler, Pennsylvania. 
2Ruger Chemical Company, Inc., Irvington, New Jersey. 
3Mallinckrodt Chemical Works, New York, New York. 
4J. T. Baker Chemical Company, Phillipsburg, New Jersey. 
5Aldrich Chemical Company, Inc., Milwaukee, Wisconsin. 
6Amend Drug and Chemical Company, Inc., Irvington, New Jersey. 
7Atla~ ~hemical Industries, Wilmington, Delaware. 
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2. Liquid Membranes1 (Designated by L.M . ) 
The liquid membranes were composed of an inte~nal aqueous 
phase of pH 10 buffer and an external oil phase. The oil phase 
was a mixture of straight and branched chain alkyls and polyamino 
surfactants. 
L.M. 573-119A 
L.M. 573-1198 
L.M. 573-120A 
L.M. 573-119A off spec 
L.M. 573-120-1, 21.6 (centipoise) (cos) 
L.M. 573-120-2, 9.9 cps 
L.M. 573-120-3, 12.8 cps 
L.M. 573-121-1, volume ratio oil/water 2:1 
L.M. 573-121-2, volume ratio oil/water 3:1 
L.M. 573-121-3, volume ratio oil/water 2:3 
L.M. 573-121-4, volume ratio oil /water 1:2 
3. Oil Phase1 
B. Supplies and Equipment 
Mettler H8 Balance; Mett~er Type H 16 Balance, Mettler Instrument 
Company, Hightstown, New Jersey. 
Photoreflectance Tachometer, model 1030, Pioneer Electric and 
Research Corporation, Forest Park, Illinois. 
Motor Generator Monomatic, Electro Craft Corporation, Hopkins, 
Minnesota. 
1Exxon Research and Engineering Company, Linden, New Jersey. 
Constant Speed and Torque Control Unit, Cole-Parmer Instrument 
Company, Chicago, Illinois. 
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Hewlett-Packard Calculator, 9810A, model 10, and Plotter (9862 A), 
Hewlett-Packard Calculators Division, Loveland, Colorado. 
Ovens, model LEFL-75, Despatch Oven Company, Minneapolis, 
Minnesota. 
Lauder Cooler IC-6, Brinkman Instruments, Westbury, New York. 
Beckman Expandomatic S5-2 pH meter, Beckman Instruments, Inc., 
Fullerton, California. 
Homogenizer 
Cylindrical Reaction Flask Body, 2000 ml, Lab Glass, Inc., 
Vineland, New Jersey. 
Microscope, Baush and Lomb. 
UV-VIS Spectrophotometer, Perkin-Elmer, Hitachi 200, Perkin Elmer , 
Norwalk, Connecticut. 
Porta-Temp with Stir Pump, Precision Scientific Company, Chicago, 
Illinois. 
Solvent Delivery System, model M6000A, Waters Associates, 
Milford, Massachusetts. 
WISP 7108, Waters Associates, Milford, Massachusetts. 
~Bondapak c18 (reversed phase) column, Waters Associates, 
Milford, Massachusetts. 
Fixed Wavelength Detector! model 440, Waters Associates, Milford, 
Massachusetts. 
Chart Strip Recorder, Cole-Parmer Instrument Company, Chicago, 
Illinois. 
Millipore Vacuum Pump, Millipore Corporation, Bedford, 
Massachusetts. 
Millipore Filter Holder, Millipore Corporation, Bedford, 
Massachusetts. 
Glassware and conman laboratory equipment as available in the 
College of Phannacy. 
C. Procedures 
1. Preparation of Donor Phase Solutions 
Standard donor phase solutions were prepared by dissolving drug 
in a 200 ml volumetric flask with either a buffer solution or hydro-
chloric acid (0.1, 0.01, or 0.001 N). Hydrochloric acid (pH 2), 
Acid ~hthalate {pH 3.5), Phosphate (pH 6.0), and Alkaline Borate 
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(pH 10) buffer solutions were prepared in accordance with USP XX. (57). 
2. Sampling Method 
A 2000 ml round bottom flask with baffled sides was mounted on a 
ring stand with a circular brace and chain clamp. The unit was 
positioned in a water bath which was thermostatically ccntro,.led 
using a Porta-Temp to maintain temperatures of 25°C and above, or an 
irrmersion cooler to maintain temperatures in the range of 4-24°C. A 
mechanically driven stirrer was introduced into the beaker and was 
operated at 250 rpm using a constant speed and torque control unit. 
The donor so l ution was poured into the flask and allowed to tempera-
ture equilibrate. An equal volume of liquid membrane, temperature 
( 
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adjusted by storage at a specif ic t e .. perature as required for at 
least 2 hours, was poured i nto t he f~ask containing the donor sol u-
tion to form a liquid membrane system (LMS ). At predetermined t ime 
intervals samples of the LMS were drawn f rom the flask us i ng a 25 ml 
glass buret at a fixed pos iti on. The samples were filtered using 
Whatman No. 42 filter paper i ini ng a glass filter and a vacuum pump 
for suction. The sample collecti on began at 10 seconds before the 
designated time to allow 5 seconds for sample withdrawal and 5 seconds 
for filtration. The sample was filtered for an additional 5 seconds 
after the designated time, thereby making the midpoint of the filtra-
tion the theoretical sampling time. The samples were assayed by 
either UV spectrophotometric or high pressure liquid chromatographic 
determinations. 
3. Sample Assay 
a. U.V. Spectrophotometric Determination 
A calibration curve was generated for each drug assay 
spectrophotometrically. Dilutions were prepared from a standard drug 
solution and the absorbance of each dilution was determined at the 
wavelength of maximum absorptivity for that drug. The absorbance 
values of salicylic acid samples were read at 236 nm, acetylsalicylic 
acid at 228 nm, and phenobarbital at 255 nm. Dilutions of salicylic 
andacetylsalicylic acid were made using the same solvent as the 
donor phase, whereas phenobarbital samples were diluted with lN 
sodium hydroxide to insure maximum absorptivity (58). 
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A Beer's plot was generated for each drug by plotting the 
absorbance of each sample dilution against the known concentration of 
the dilution. Beer's law states: 
A = abC Equation (14) 
Where: A = absorbance, 
a = absorptivity, 
b = sample path lengt~ 
c = concentration. 
Applying Beer's law, the slope of the straight line obtained by 
the absorbance versus concentration plot is equivalent to the term ab 
in Equation (14). 
By rearranging Equation (14) to 
C = A/slope Equation (15) 
the concentration of an unknown sample may be calculated. 
b. High Pressure Liquid Chromatographic Determination (HPLC) 
A calibration curve was generated for each drug assayed by high 
pressure liquid chromatography (HPLC). The HPLC system included a 
Waters Intelligence Sample Processor (WISP) unit which was prograrrmed 
to inject automatically a range of sample volumes from one standard 
solution into the system for assay. For each drug, a series of 
dilutions from a standard solution was made also and the absorbance of 
each sample was determined. A Beer's plot was obtained for each drug 
by plotting the absorbance of each sample volume or sample dilution 
against its known concentration. Based on the principles described 
above in section 3 a, these plots were used to determine unknown 
concentrations of solutes. 
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The HPLC sys~em used in these experi ments consisted of a solvent 
delivery syst m, the ~ISP unit for automa :ic and prec i se sampl e i , j e~ ­
tion, and a f ixed wavelength detector with i nterchangeable lamps . 
The separation was performed on a 3.9 mm (i d) x 30 cm µBondapak c18 
(reversed phase) column. The chromatograph i c peaks were recorded 
using a chart recorder. 
The mobi l e phase employed in the analysis of salicylic acid and 
acetylsalicyl ic acid consisted of acetic acid 1%:methanol (40:60) with 
the following chromatographic conditions: flow rate - 1.5 ml/min.; 
detector wavelength - 280 nm; injection volume 25 or 50 µl (59). 
To assay phenobarbital, the following chromatographic conditions 
were employed (60): flow rate - 2.0 ml/min.; detector wavelength -
254 nm; injection volume - 100 µ1. The mobile phase consisted of 
double distilled water:acetonitrile:phosphate buffer (80 µl lM KH 2Po4; 
14 µl H3P04; 500 ml double distilled water) (11:19:70). 
4. Preparation of Emulsions 
a. Using the HLB Approach 
Sixty milliliter quantities of 50% water-in-mineral oil emulsions 
were prepared using blends of emulsifying agents having a HLB of 6.0 -
the HLB of mineral oil. The ratio of emulsifiers required to achieve 
this HLB was determined using Equations ( 9) and (10). 
The emulsions were prepared by adding 33.3 ml of mineral oil to the 
emulsifier blend and heating to 72°C. The required quantity of 
aqueous phase, also heated to 72°C.was poured into a clear 120 ml 
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bottle containing the heated oil/surfactant mixture. The total 
preparation was hand shaken for 2 mirutes and stored at room 
temperature. 
In order to scale-up the quantity of emulsion prepared, the same 
procedure was followed using a homogenizer instead of the bottle for 
mixing. The tota1 preparation was homogenized for 1.5 minutes. 
b. Using the Davis Approach 
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Sixty milliliter quantities of water-in-mineral oil emulsions (50%) 
were prepared based on a formula developed by Davis (19) (see Table I). 
The required quantities of ingredients comprising the oil phase were 
heated to 72°C, as was the aqueous phase. The two phases were hand 
shaken in a clear 120 ml bottle for 2 minutes and stored at room 
temperature. 
In order to scale-up the quantity of emulsion prepared, the same 
procedure was followed except a homogenizer was used for 1.5 minutes 
instead of the bottle for mixing. 
TABLE I 
FORMULA FOR WATER-IN-OIL-IN-WATER EMULSIONS (19) 
Oil Phase 
50% Mineral Oil 
10% Span 80 
2% Tween 80 
10% Cetyl Alcohol 
10% Aluminum Tristearate 
*Percent not specified 
Aqueous Phase (Internal) 
Methocel 4000* 
( 
5. Analysis of Emulsions 
a. Visual 
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After preparation, emulsions were analyzed visually in terms of 
color and physical stability. Observations were made immediately and 
24 hours after manufacture. The emulsions were classified according 
to color from white to shades of white to gray, with white indicating 
the better emulsions. The emulsions were inspected for phase separa-
tion as an indication of physical stability. 
Although it is appreciated that these visual observations are 
inherently subjective in nature, these evaluation methods are accepted 
both academically and industrially and the researche~ has used these 
techniques to evaluate emulsions in previous research experiments. 
b. Determination of Emulsion Type 
Emulsion type was determined immediately and 24 hours after 
preparation using an aqueous dilution test. A drop of emulsion was 
introduced into a beaker containing pH 2 buffer. If the drop of 
emulsion readily dispersed upon contact with the buffer solution, the 
emulsion was considered to be oil-in-water; whereas if the droplet 
remained in a spherical form, the emulsion was considered water-in-oil. 
c. Evaluation of Potential to Form a Liquid Membrane System 
The potential of the w/o emulsions to form a liquid membrane system 
(w/o/w emulsion) was evaluated immediately and 24 hours after prepara-
tion. An aqueous dispersion test was used to make this evaluation. 
Several milliliters of emulsion were poured into a beaker containing 
pH 2 buffer. The buffer was stirred using a magnetic stirrer. If the 
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emulsion broke up into stable, intact drops which dispersed throughout 
the buffer solution and could be separated from the buffer solution 
upon filtration, the emulsion was considered to hdve good potential 
for forming a liquid membrane system. The emulsion was considered 
unsuitable for forming a liquid membrane system if one of the following 
occurred: the emulsion dispersed readily as evidenced by the formation 
of a cloudy external aqueous phase which could not be separated upon 
filtration, or if the emulsion underwent phase inversion and mixed 
with the buffer. 
d. Rheological Determination and Characterization of Flow 
For those emulsions which could flow through an Ostwald viscometer, 
viscosity measurements were made . This was accomplished by determining 
the time required for a volume of emulsion to flow through the capil-
lary tube of an Ostwald viscometer, size 350, and employing the 
following equation: 
nu = nk (du\/dktk) Equation (16) 
Where: du = the density of the emulsion, 
dk = the density of water, 
tu = the time required for the volume of emulsion to flow 
through the tube, 
tk = the time required for the volume of water toflm-J through 
the tube, 
nu = the viscosity of the emulsion, 
nk = the viscosity of water . 
( 
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For those emulsions which har poor flow, the ease of shaking and 
pourability served as indicators of viscosity. Emulsions were 
characterized by ease of shaking and pourability and rated on a basis 
of 1 to 5 with the following key: 
1 = very good 
2 = good 
3 = average 
4 = difficult 
5 = poor. 
( 
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IV. EXPERIMENTAL 
The sampling method and assay techniques as described in 
Section III were employed to study the ki netics of solute transfer in 
liquid membranes under the various conditions listed in this section. 
All experiments were carried out at 25°C for 120 minutes unless 
otherwise indicated. 
A. Effect of Initial Donor Phase Concentration on Acetylsalicylic 
Acid Uptake 
The effect of varying initial donor phase concentration on the rate 
of solute uptake was studied using acetylsalicylic acid in concentra-
tions of 1.0 g/l and 0.5 g/l in O.lN HCl (pH 1) and L.M. 573-119 B. 
Collected samples of filtrate were subjected to UV spectrophotometric 
analysis. Six replicate runs for acetylsalicylic acid 1.0 g/l and 
five replicate runs of the drug at 0.5 g/l were conducted , thereby 
allowing evaluation of the reproducibility of the sampling technique. 
B. Effect of Donor Phase Molar Concentration on Salicylic Acid Uptake 
The effect of varying the initial molar concentration of solute on 
the rate of solute uptake was investigated using various molar con-
centrations of salicylic acid in pH 2 buffer and L.M. 573-120 A. Two 
replicate runs were perfor~ed at the following concentrations: 
2.5 mM, 4.1 mM, 7.2 mM. A single run was performed a t a concentration 
of 5.6 mM. Each run was 10 minutes in length and t he filtrate was 
assayed by HPLC. 
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C. Effect of Liquid Membrane Viscosity on Salicylic Acid Uptake 
The effect of liquid membrane viscosity on the rate of uptake of 
salicylic acid 1.0 g/l in pH 2 buffer was investigated using the 
following liquid membranes: L.M. 573-119 B (16.7 cps), L.M. 573-119 A 
(3.0 cps), L.M. 573-120-1 (21.6 cps), L.M. 573-120-2 (9.9 cps), 
573-120-3 (12.8 cps). 
Two replicate runs were completed with sample collection each 
minute for 10 minutes and subsequent HPLC analysis for each liquid 
membrane except L.M. 573-119 3. For this membrane, samples were 
collected for 120 minutes with subsequent UV spectrophotometric 
analysis. 
D. Effect of Liquid Membrane Oil/Water Ratio on Salicylic Acid Uptake 
The effect of liquid membrane oil/water ratio on the rate of uptake 
of salicylic acid 1.0 g/l in pH 2 buffer was investigated using the 
following liquid membranes: 
Liguid Membrane Oil/Water Ratio 
L.M. 573-120 A 1:1 
L.M. 573-121-1 2:1 
L.M. 573-121-2 3:1 
L.M. 573-121-3 2:3 
L.M. 573-121-4 1:2 
Two replicate runs were performed using each liquid membrane with 
sample collection every minute for 10 minutes and subsequent HPLC 
analysis. 
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E. Effect of Donor Phase pH on Solute Uptake 
1. Acetylsalicylic Acid 
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Two replicate runs were performed to determine the effect of donor 
phase pH on the rate of uptake of acetylsalicylic acid 1.0 g/l using 
L.M. 573-119 B. Three different pH donor solutions were investigated: 
pH 1 (O.lN HCl), pH 2 (O.OlN HCl), and pH 3 (0.00lN HCl). The pH of 
the donor phase solution was measured at the onset (t = 0) and the 
end (t = 120 minutes) of each run. The filtrate was analyzed using the 
UV spectrophotometer. 
2. Salicylic Acid 
Using L.M. 573-120 A Off Spec, two replicate runs were performed to 
determine the effect of donor phase pH on the rate of salicylic acid 
1.0 g/l uptake. Buffer solutions of pH 1, pH 2, pH 3.5, and pH 6.0 
were ~sed as donor solutions with the pH measured at the beginning and 
end of each run (t = 0 and t = 120 minutes). Collected samples of 
filtrate were subjected to HPLC analysis. 
F. Effect of Temperature on Solute Uptake 
1. Salicylic Acid 
The effect of temperature on the rate of uptake of salicylic acid 
1.0 g/l in O.lN HCl donor solution was investigated using L.M. 573-119A. 
The temperatures studied were 4°, 16°, 28°, 37.5°, and 50°C. Two 
replicate runs were performed at each temperature and samples collected 
were assayed by HPLC. 
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2. Phenobarbital 
Using L.M. 573-119 A, the effect of temperature on the rate of 
uptake of phenobarbital 0.6 g/l in pH 2 buffer was studied at 4°, 20°, 
37.5°, 41°, 42°, 43°, and 45°C. Two replicate runs were performed at 
each temperature with an additional two runs performed at 43°C. Samples 
were collected and assayed by HPLC. 
G. Effect of Liquid Membrane Viscosity on Phenobarbital Uptake at a 
Critical Temperature - 43°C 
The effect of liquid membrane viscosity on the rate of uptake of 
phenobarbital 0.6 g/l in pH 2 buffer at 43°C was investigated. Two 
replicate runs were performed using each of the following liquid 
membranes: L.M. 573-120-1, L.M. 573-120-2, L.M. 573-120-3. Samples 
collected were assayed by HPLC. 
H. Evaluation of Liquid Membrane Reuse 
1. Transport of Trapped Solute 
Figure 3 depicts the experimental sequence used to investigate the 
integrity of liquid membranes for reuse and their ability to release 
trapped drug using L.M. 573-120 A. Two replicate uptake runs were 
performed using each of the three investigational drugs - phenobarbital 
0.6 g/l in pH 2 buffer, salicylic acid 1.0 g/l, and acetylsalicylic 
acid 1.0 g/l each in O.OlN HCl. A drug free pH 2 buffer donor solution 
served as a control. At the end of the 120 minute sampling period, the 
rema ~ ning liquid membrane system (external donor phase/liquid membrane 
mixture), designated LMS I, was collected, measured, and mixed in a 
beaker until further use. The glassware used in the initial uptake 
run was washed and dried. 
( 
External Phase 
Drug A 
Sample & Assay 0 - 2 
External Phase 
Hours 
.. 
Liquid Membrane 
System I 
Mix X 2 Hours 
Liquid 
Membrane 
Exter '1a1 
Bu Fer 
> 2 Hours 
, 
Liquid Membrane 
System II 
Mix X 2 Hours 
0 - 2 Hours 
Sample & Assay 
External Phase 
Drug A 
Fig. 3 Experimental Sequence for Liquid Membrane Reuse 
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A dr~g free pH 10 buffer solution was used as the external aqueous 
phase for the second part of the experiment. A drug free pH 2 buffer 
solution was used also for the second portion of one phenobarbital 
experiment. LMS I was mixed ¥1ith the pH 2 or pH 10 buffer to form 
LMS II and the experiment proceeded according to the standard sampling 
method for 120 minutes. Collected samples were assayed using the UV 
spectrophotometer to dett:rmi ne if the drug had remained trapped \'Ii thin 
or if it had transported out of the membrane. 
2. Evaluation of Subsequent Solute Uptake 
The experimental scheme depicted in Figure 4, was devised in order 
to investigate the ability of liquid membranes to be reused for the 
purpose of subsequent solute uptake. Using L.M. 573-119 A, an uptake 
experiment using either salicylic acid 1.0 g/l in O.lN HCl or 
phenobarbital 0.6 g/l in pH 2 buffer was conducted for 120 minutes with 
HPLC sample analysis. The liquid membrane system remaining at the end 
of the run (LMS I) was collected, measured, and mixe~ in a beaker 
until further use. The glassware used in the initial uptake run was 
washed and dried. 
A pH 2 buffer solution containing either salicylic acid 1.0 g/l or 
phenobarbital 1.2 g/l was used as the external aqueous phase for the 
second part of the experiment. Samples collected from LMS II for 
120 minutes were assayed for both drugs. Table II lists the order of 
drug uptake and the temperature at which the experiment was run. 
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External Phase 
Drug A 
Sample & Assay 
Externa 1 Phase 
0 - 2 
Hours 
t. 
Liquid Membrane 
System I 
Mix X 2 Hours 
Liquid 
Membrane 
• 
External Phase 
~ 
> 2 Hours 
l 
Liquid Membrane 
System II 
Mix X 2 Hours 
0 - 2 Hours 
Sample & Assay 
External Phase 
Drugs A & B 
Fig . 4 Experimental Sequence for Subsequent Uptake of Solutes 
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TABLE II 
ORDER OF SUBSEQUENT SOLUTE UPTAKE 
Initial Solute Subsequent Solute Temperature oc 
Salicylic Acid Phenobarbital 50 
Phenobarbital Salicyl i c Acid 37.5 
Phenobarbital Salicylic Acid 45 
I. Evaluation of Co-Uptake of Solutes from One Donor Solution 
1. Co-Uptake of Solutes with Different Initial Molar Concentrations 
Two replicate runs were conducted to determine the effect of the 
presence of one solute on the rate of uptake of another solute when 
the initial concentrations of each solute were different. Table III 
lists the combinations of solutes and their initial concentrations in 
pH 2 buffer. L.M. 573-120 A was used in these experiments. Samples 
collected were assayed using HPLC. 
TABLE III 
CO-UPTAKE OF SOLUTES WITH DIFFERENT iNITIAL CONCENTRATIONS 
External Aqueous Phase Solutes Molar Concentration (mM) 
1 Salicylic Acid 7.2 
Acetylsalicylic Acid 5.6 
2 Salicylic Acid 7.2 
Phenobarbital 2.5 
3 Acetylsalicylic Acid 5.6 
Phenobarbital 2.5 
50 
2. Co-Uptake of Solutes with Equimolar Initial Concentrations 
Two replicate runs were conducted to determine the effect of the 
presence of one solute on the rate of uptake of another when their 
initial concentrations were equimolar. Table IV lists the combinations 
of solutes and their initial concentrations in pH 2 buffer. L.M. 573-
120 A was used in these experiments. Samples collected were assayed 
using HPLC. 
TABLE IV 
CO-UPTAKE OF SOLUTES WITH EQUIMOLAR INITIAL CONCENTRATIONS 
External Aquecus Phase So 1 utes· Molar Concentration (mM) 
1 Salicylic Acid 5.6 
Acetylsalicylic Acid 
2 Saiicylic Acid 2.5 
Phenobarbital 
J. Effect of Liquid Membrane Oil/Water Ratio on the Co-Uptake of 
Solutes 
Two replicate runs were perfonned to study the effect of liquid 
membrane oil/water on the co-uptake of solutes having different initial 
molar concentrations. The solutes and their molar concentrations were 
phenobarbital 0.6 g/l (2.5 mM) and salicylic acid 1.0 g/l (7.2 mM). 
The samples collected were assayed using HPLC. The liquid membranes 
used were: L.M. 573-120 A, L.M. 573-121-1, L.M. 573-121-2, L.M. 573-
121-3, L.M. 573-121-4. 
K. Effect of Freeze/Thaw on the Use of Liquid Membranes 
The effect of freeze/thaw stress on the perfonnance ot liquid 
membranes to take up solutes was investigated. Approximately 100 ml 
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of the following liquid membranes were frozen for at least 24 hours, 
thawed, and stored at room temperature for at least 24 hours: 
L.M. 573-120-1, L.M. 573-120-2, L.M. 573-120-3. These membranes were 
used for the uptake of salicylic acid 1.0 g/l in pH 2 buffer. The 
membranes were observed for cracking after freezing. 
L. Fonnulations 
1. Using the HLB Approach 
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Table V describes the emulsions prepared by the procedure described 
in Section III, C-4a. These emulsions were analyzed as described in 
Section III, C-5. 
2. Using the David Approach 
Table VI lists the emulsions prepared as described in Section III, 
C-4b. These emulsions were analyzed as described in Section III C-5. 
Emulsion 
1 
2 
3 
4 
5 
6 
**7 
8 
9 
,,,--..._ ...-...., 
TABLE V 
PRELIMINARY FORMULATIONS AND FORMULATIONS OF EMULSIONS PREPARED USING THE HLB APPROACH 
Surfactant Blend (% weight of total 
emulsifier in blend) 
Span 80 (50 
Tv~een 80 ( 50) 
Span 80 (66) 
Tween 80 (33) 
Span 80 (83) 
Tween 80 (17) 
Span 80 (83) 
Tween 80 (17) 
Span 60 (66) 
Tween 60 (33) 
Span 60 (71) 
Tween 60 (29) 
Span 60 (87) 
Tween 60 ( 13) 
Span 80 (84) 
Tween 80 (16) 
Span 80 (84) 
Tween 80 (16) 
% Weight of Total 
Emulsifying Agent 
in Oil Phase*** 
20 
15 
12 
12 
15 
7 
5 
5 
10 
Additives (% Weight of Total 
in Oil Phase)*** 
- (Comment: Distilled 
water, not pH 10 buffer 
used as internal phase) 
Cetyl Alcohol (20~ 
tJl 
N 
.... ~-..... 
TABLE V {Continued) 
Surfactant Blend % Weight of Total Additives 
Emulsion (% Weight of total Emulsifying Agent (% Weight of Total 
emulsifier in blend) in Oil Phase*** in Oil Phase)*** 
10 Span 80 (84) 15 
Tween 80 (16) 
11 Span 60 (87) 5 
Tween 80 ( 13) 
12 Span 60 (87) 10 
Tween 80 (13) 
13 Span 60 (87) 7.5 
Tween 80 ( 13) 
14 Span 80 (84) 10 Cetyl Alcohol (1) 
Tween 80 (16) 
15 Span 60 (87) 6.25 
Tween 80 (13) 
16 Span 60 (87) 6 
Tween 80 {13) 
17 Span 60 (87) 5.75 
Tween 80 (13) 
18 Span 60 (87) 5.5 
Tween 80 ( 13) 
19 Span 60 (87) 5.25 
Tween 80 (13) (.]1 w 
TABLE V (Continued) 
Emulsion 
20a 
b 
2la 
b 
Surfactant Blend (% Weight of total 
emulsifier in blend) 
Span 80 (86.5) 
Myrj 52 (13.5) 
Span 80 (86.5) 
Myrj 52 (13.5) 
*Preliminary emulsions not using HLB approach. 
** Using HLB approach. 
% Weight of Total 
Emulsifying Agent 
in Oil Phase*** 
10 
15 
Additives (% Weight of Total 
in Oil Phase)*** 
*** The weight of the surfactant blend and additives was based on that percentage of the 50% oil phase. 
a Hand homogenized. 
b Use of homogenizer. 
(J1 
~ 
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Emulsion 
101-105 
106-109 
TABLE VI 
EMULSIONS PREPARED AS VARIATIONS OF THE DAVIS 
FORMULA (19) 
Variation 
Decreased percent cetyl alcohol 
Changed percent methocel in aqueous phase 
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V. RESULTS AND DISCUSSION 
This section contains an evaluation of the experimental protocol 
and assay techniques used in this study and reports the results 
obtained. Also, this section contains a critical discussion of the 
significance and possible interpretation of the results. 
The conclusions to be drawn from this study and suggestions for 
further investigations are presented in the section, Conclusions. 
For ease of reference, the results and discussion are organized 
into the following main sections: 
A. General Considerations 
B. Evaluation of Assay Methods and Sampling Technique 
C. Effect of Initial Donor Phase Concentration on the Rate of 
Solute Uptake 
D. Effect of Liquid Membrane Oil/Water Ratio on the Rate of 
Salicylic Acid Uptake 
E. Effect of Donor Phase pH on the Rate of Solute Uptake 
F. Effect' of Viscosity on the Rate of Salicylic Acid Uptake 
G. Effect of Temperature on the Rate of Solute Uptake 
H. Effect of Viscosity on the Rate of Phenobarbital Uptake at a 
Critical Temperature 
I. Evaluation of Liquid Membrane Reuse 
J. Evaluation of Co-Uptake of Solutes From One Donor Phase 
K. Effect of Freeze/Thaw on the Use of Liquid Membrane 
L. Evaluation of Some Fonnulation Aspects of Liquid Membranes 
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A. General Con~~derations 
1. Autoan Analysis of the Data 
In the Autoan (61) analysis of the data, the best apparent 
compartment model fit chosen to describe the uptake of drug from the 
donor phase was in many instances a one compartment model. This 
differs somewhat from the two compartment approach proposed by Yang 
and Rhodes (17) as referred to in Section III of this thesis. The 
difference can be explained through characterization of the a phase 
of the process. The a phase may be described as a rapid initial 
decline of drug concentration from a particular compartment which is 
followed by a slower decline or e phase (62). Applying this, as Yang 
and Rhodes did for some systems, to the uptake of solute by a liquid 
membrane, the a phase is the distributive portion of the process in 
which the drug leaves the external donor phase and distributes into the 
oi l or liquid membrane phase . Measurement of the a rate constant 
controlling this process is rather restrictive. The a phase is often 
very short-term; thus in many liqu i d membrane ex periments the 
11 feathering 11 technique used to define the a phase results in the 
accumulation of only three which could be legitimately used to estimate 
the a rate. It is noteworthy that in the paper by Yang and Rhodes 
(see Tables I and II of t heir work (17)), in many instances only two 
points were available for estimation of a ; however, there were some 
instances where as many as 11 points could be used for that purpose. 
In their work, Yang and Rhodes also reported t hat their data showed 
that the simple model yielding the equation wh i ch describes a two 
compartment model (Equation 13 of this thesis), is JI .. suitable 
for the definition of the kinetics of transport across a liquid 
membrane.JI They further state that in a previous paper by 
Chang, et~· (16), 11 it was reported that the uptake of drugs 
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by liquid membranes obeyed simple first-order kinetics. For those 
systems in which the a phase is very short, the description will 
essentially be valid for all practical purposes. However, for other 
systems, the s phase will be of greater magnitude than a and thus the 
apparent simple monoexponen~ial kinetics will be obeyed." (17). 
Variation in the a values is greater than that observed for the 
s values. The method of sampling prohibits the acquisition of more data 
points in the early a stages of the experiment. As Yang and Rhodes 
have points out, 11 • errors in sampling times are relatively 
greater at the start of experiments than at later times 11 (17). Thus, 
those data points acquired for the a phase of a process are subject 
to more error than those points of the s phase. Although the s rate 
constants may be determined from actual experimental points, t he a rate 
constant is calculated indirectly by a "feathering" technique (62). 
Although Autoan was used to indicate the best mathematical fit of 
the data (i.e. one or two compartment model), the simplest model that 
adequately described the data was chosen when di fferences between the 
two models were not sufficient to justify the use of the more complex 
two compartment model. In the two cases in which this procedure was 
adopted, the difference in the value assigned to the apparent B ·rate 
constant by use of the one or two compartment model was very small, 
as illustrated in Table VII. 
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TABLE VII 
COMPARISON OF APPARENT S VALUES FROM ONE AND TWO 
COMPARTMENT i·10DEL FITS 
System Apparent Best Fit 
Apparent S Rate Constants 
x 10-2 (min-1) 
Compartment Model 
Salicylic Acid 1.0 g/l 
at pH 6 
Salicylic Acid 1.0 g/l 
LM 21. 6 cps 
two compartment 
two compartment 
2. Significance of the Results 
1 2 
a1 = o.so s = 0.43 1 
The application of significance to the results has been viewed in 
three ways. 
The first is data which appears to be different by inspection but 
when tested statistically, the differences were not significant. 
Although the Student's T test does not show the means to be signifi-
cantly different, the data may be reviewed for possible trends. 
Increasing the sample size may help to clarify these cases. Obtaining 
additional data was hampered by the limited availability of the liquid 
membrane supplied by Exxon Research and Engineering Company. 
Secondly, in some situations the acquisition of more data may 
prove it to be statistically significant; however, from a practical 
point of view, were these liquid membranes to be used for the purpose 
of drug delivery, it may appear that the differences \'/ould not be 
significantly large to be of practical importance. 
In the final case, the data was found to be statistically 
significant and also of likely practical significance. An example of 
( 
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this is the situation in which the ~atr. constants between different 
initial donor phase concentrations were determi~ed to be significant. 
This finding also has an effect on the efficiency of the liquid 
membrane to function under varicus conditions. For example, one 
potential use of liquid membranes is their application as 11 sinks 11 for 
trapping drug in the case of drug overdose. In such a situation it is 
obviously important that the ability of the liquid membrane to trap 
drug should be essentially independent cf the concentration of the 
drug in the external aqueous phase (in this case the lumen of the 
gastro-intestinal tract). The fact that, as detennined by this inves-
tigation, increasing the external aqueous phase concentration of 
solute tends to reduce trapping efficiency is unfortunately an indica-
tion of a possible practical limitation in liquid membrane use for the 
treatment of drug overdose. 
B. Evaluation of Assay Methods and Sampling Technique 
1. Assay Methods 
Beer's plots for acetylsalicylic acid, salicylic acid, and 
phenobarbital are presented in Appendix I. A linear relationship was 
found to exist between concentration and absorbance for each drug using 
both conventional UV spectrophotometry (i.e. without a separation 
technique) and HPLC with UV detection (automatic and manual dilutions) 
(see Appendix I). 
In the i nitial stages of this project, conventional UV spectro-
photometric assays were used to determine the concentration of drug 
remaining in the external donor phase over a period of time. Recog-
nizing the limitations of this conventional technique, an HPLC assay 
( 
with UV detection (referred to as HPLC) was selected as a more 
sensitive and reliable method which would aid in a more thorough 
explanation of the processes studied. 
At very low concentrations unreliable absorbance readings are 
likely using UV spectrophotometry without HPLC separation. The 
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signal to noise ratio is smaller at low concentrations with imprecise 
readings resulting. Since the passage of part of the incident 
radiation through the sample cell may occur more than once due to 
repeated reflections by the front and back of the cuvette surface, 
higher than actual absorbance readings may result (63). Absorption 
of stray light by the sample due to lack of a monochromatic light 
source or extraneous light entering the sample, particles such as 
fibers in the analysis solution, or dirty cuvette surfaces may produce 
inaccurate readings. 
HPLC can be used to identify and quantify a compound with a high 
degree of sensitivity. The sensitivity of the HPLC techniques used in 
this project was demonstrated in two ways. Firstly, the qua l itative 
sensitivity was determined. For example, it was noted by absorbance 
readings using the UV spectrophotometer that the complete uptake of 
salicylic acid had apparently occurred within a period of ten minutes. 
Using HPLC the presence of drug was detected over the course of 120 
minutes. By changing the absorbance units full scale on the detector, 
sharp, measurable drug peaks were recorded, thereby verifying the 
presence of drug i~ the donor phase. A comparative study of detected 
drug in the donor phase over the period of 120 minutes using each 
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TABLE VIII 
COMPARISON OF DETECTED DRUG IN THE DONOR PHASE 
USING TWO ANALYTICAL METHODS 
Method of /l.ssay 
Time UV HPLC 
(min) Absorbance Concentration Absorbance Units Peak Concentration 
( g/l) Full Scale Height ( g/l) 
(mm) 
0 1.215 0.983 2.0 11.6 0.950 
1 0.489 0.396 2.0 11.3 0.462 
2 0.358 0.290 2.0 8.7 0.350 
3 0.319 0.259 1.0 11. l 0.214 
4 0.247 0.200 1.0 8.6 0.160 
5 0.179 0.145 0.5 11.2 0.096 
( 6 0.130 0.106 0.5 7.9 0.060 
7 0.105 0.085 0.2 12.0 0.027 
8 0.092 0.075 0.2 7.1 0.006 
9 0.1 3.7 <0.001 
10 0.046 0.038 0.1 1.8 
12 0.018 0.015 0.02 0.08 
14 0.007 0.006 0.02 7.1 
16 0.004 0.005 6.2 
18 0.002 0.005 5.0 
20 0.003 0.005 5.8 
25 0.005 4.3 
40 0.002 0.005 3. 4 
50 0.003 0.005 4. 2 
60 0.003 0. 005 3.0 
( 
( 
method of assay is presented in Table VIII. Although very low 
absorbance readings were obtained, thus indicating the presence of 
drug, using UV spectrophotometry, the limitations of the technique 
suggest in fact that no drug was present in the sample. 
Secondly, quantitative sensitivity of the HPLC technique was 
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demonstrated as presented in Table IX. It is generally accepted that 
absorbance readings of less than 0.200 are not recommended for 
quantitative use (refer to Table V1In. Levels of acetylsalicylic 
and salicylic acid as low as 0.1 µg/ml and 1.3 µg/ml for phenobarbital 
can be accurately detected with the appropriate HPLC system. 
TABLE IX 
COMPARATIVE SENSITIVITY OF UV SPECTROPHOTOMETRY AND HPLC 
Minimal Quantifiable Sensitivity of 
Drug Concentration (µg/ml) HPLC : UV Spec-
UV Spectrophotometry HPLC trophotometry 
Acety1salicylic Acid 4.0 0.1 40:1 
Salicylic Acid 3.0 0.1 30:1 
Phenobarbital 6.0 1.3 4:1 
In addition to being sensitive and reliable, HPLC is an accurate, 
precise and reproducible technique. The technique involved less 
manipulation of the sample since, unlike UV spectrophotometry, no 
dilution was required. Using the WISP method of sample injection 
permitted small, accurate and reproducible injection volumes. The 
accuracy and precision the HPLC systems employed in this study were 
evaluated ·using the three drugs at three concentrations within each 
( 
( 
( 
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appropriate system. Five samples of each test solution were analyzed 
for drug content. In each case the accuracy and prec i sion were good 
with the exception of salicylic acid, 10 µg/ml and phenobarbital 
60 µg/ml, as can be seen by the data presented in Table X. The 
technique was reproducible as demonstrated by constancy of retention 
times and peak heights of standard concentratio~s over the course of 
the study. 
An advantage of particular importance to this work is the ability · 
of HPLC to be a differential assay, thereby allowing analysis of two 
or more drugs without interference. This added another dimension to 
the study of drug transport across liquid membranes - investigation of 
co-uptake of drugs from one donor phase solution. Figure 5 shows the 
baseline separation obtained when acety l salicylic and salicylic acids . 
are in solution together. Figure 6 shows a typical chromatogram 
obtained for phenobarbital. 
The HPLC assays used in this study were si milar to those described 
in the literature (59,60). However, unlike the assay described in 
the Water's Product Literature (60), in this project detection of 
phenobarbital was ach ·ieved at 254 nm rather than 195 nm. The assay was 
adapted for use with a 254 nm lamp with good accuracy, precision, and 
sensitivity. Use of this wavelength was necessary since a variable 
wavelength detector was not available. The fact that the a~say could 
be run with satisfactory results at 254 nm, a generally available 
wavelength, is of considerable value. 
-TABLE X 
ACCURACY AND PRECISION OF HPLC TECHNIQUE 
Acetrlsalic~lic Acid --~~ l i cyl i~ /\ci d Phenobarbital 
Concentration Detected Difference Detected Difference Concentration Detected Difference µg/ml (µg/ml) (µg/ml) ( µg /ml) (µg/ml) µg/ml {µg/ml) (µg/ml) 
-
5.0 5. 0 0.0 5.1 r.1 15.0 14.9 0. 1. 
4.5 0.5 5.2 0.2 14.8 0.1 
4.8 0.2 5.0 0.0 14.8 0.2 
4.8 0.2 5.0 0.0 14 .9 0.1 
4.9 0.1 4.7 0.3 14.8 0.2 
4.8±0.1* 4.0%*** 5.0±0.2* 0 %*** 14.8±1* 0.9%*** 
3.9%** 3.7%** 0.4%** 
10.0 10.3 0.3 11.8 1.8 30.0 30.9 0.9 
10.1 0.1 12.1 2.1 31.3 1.3 
10.3 0.3 11.9 1. 9 30.4 0.4 
10.1 0.3 12.1 2.1 31.3 1.3 
10.2±0.1* 0.1 12.1 2.1 30.9 0.9 
1.0%** 2.2%*** 12.0±0. ±* 20. 0%**'* 31. 0±0.4* 3.2%*** 
1. 2* 1.2%* 
25.0 25.9 0.9 27.1 2.1 60.0 61.0 1.0 
25.9 0.9 27.7 2.7 62.6 2.6 
25.5 0.5 26.7 1. 7 63.0 3.0 
25.9 0.9 28.0 3.0 62.6 2.6 
25.9 0.9 27.8 2.8 62.1 2.1 
25.8±0.2* 2.4%*** 27.5±0.5* 9.8%*** 62.3±0.8* 26.5%*** 
1.0%** 2.0** 1.2%** 
*Mean ± SD ** Coefficient of variation *** Relative Error 
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2. Evaluation of Sampling Technique 
The sampling technique was quite reproducible. Table XI lists the 
percent of acetylsalicylic acid 1.0 g/l remaining in the external donor 
phase at various times over 60 minutes for six replicate experimental 
runs. Table XII lists the same data for five replicate runs of the 
drug at a concentration of 0.5 g/l. Low standard deviations were 
noted at each time point throughout the experimental runs. A plot of 
concentration versus time for the two sets of data can be found in 
Figures 7 and 8. 
C. Effect of Initial Donor Phase Concentration on the Rate of 
Solute Uptake 
1. Acetylsalicylic Acid 
The rate of uptake of acetylsalicylic acid as a function of initial 
donor phase concentration was investigated (refer to Figures 7 and 8). 
The apparent s rate constants for each replicate run of acetylsalicylic 
acid 1.0 g/l and 0.5 g/l and the mean apparent s rate constants are 
listed in Table XIII and XIV. The mean apparent s ra t e constant was 
higher for the lower concentration of acetylsalicylic acid. This 
proved to be a statistically significant di fference. 
Alteration of the properties of the membrane surface may occur at 
the external donor phase/liquid membrane interface or at the liquid 
membrane/internal donor phase interface. It is possibl e that an 
interaction between the solute and the surfactant causes an alteration 
in one or both of these surfaces which may alter the transport of drug 
to allow a modification of diffusion either into or out of the liquid 
membrane. 
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TABLE XI 
COMPARISON OF PERCENT ACETYLSALICYLIC ACID 1.0 g/l REMAINING 
IN EXTERNAL AQUEOUS PHASE AFTER TREATMENT WITH LIQUID MEMBRANE 
AT VARIOUS TIMES IN SIX REPLICATED EXPERIMENTS 
Time Replicates Mean 
(mins) 1 2 ., 4 5 6 (±1 SD) ..., 
0 100.00 100.00 100.00 100.00 100.00 100.00 100±0 
1 95.54 92.35 91.34 90.45 90.15 92.90 92 .12±1. 98 
2 90.74 89.14 88.38 87.98 87.55 88.70 88. 75±1.12 
3 88.57 87.58 85.42 86.29 81.28 82.35 85.25±2.89 
4 79.86 78.16 80.59 81.57 79.76 77 .07 79. 50±1.64 
5 75.05 75.17 75.66 74.83 74.89 74.49 75.02±0.39 
6 74.06 73.61 71.49 69.44 70.77 72.34 71. 95±1. 75 
7 67. 77 68.96 67.32 70.22 66.99 68.99 68. 38±1. 23 
( 8 65.03 64.09 64.34 63.71 63.74 64.80 64.79±1.37 
9 61. 71 61.09 60.09 60.56 59.52 61.36 60.72±0.82 
10 53.25 60.31 57.89 54.94 58.23 58.45 57.18±2.59 
12 54.21 53.51 49.55 51.62 52.96 52.37±1.84 
14 46.06 48.00 46.82 42.92 46.65 49.09 46.59±2.10 
16 41.60 44.90 42.76 39.66 41.02 43.16 42 .18±1.83 
18 38.34 39.25 38.38 33.48 37. 77 39.61 37.81±2.22 
20 32.34 35.70 33.88 32.46 33.66 35.52 33. 76±1. 68 
25 23.39 26.72 25.33 23.03 25.87 27.99 25. 38±1. 93 
30 16.23 19.40 16.01 17.87 19.37 21.20 18.33±2.00 
40 8.23 10.98 9.54 10.45 10.93 11.30 10.24±1.16 
50 4. 69" 5.66 4.93 6.07 7.68 6.35 5. 90±1. 08 
60 3 :77 3.99 2~85 2.58 4.22 3.34 3.29±0.61 
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TABLE XII 
COMPARISON OF PERCENT ACETYLSALICYLIC ACID 0.5 g/l REMAINING 
IN EXTERNAL AQUEOUS PHASE AFTER TREATMENT WITH LIQUID MEMBRANE 
AT VARIOUS TIMES IN FIVE REPLICATED EXPERIMENTS 
Time Replicates Mean 
(mins) 1 2 3 4 5 ±1 SD 
0 100.00 100.00 100.00 100.00 100.00 100.00±0 
1 88. 77 93.36 86.96 91.30 90.41 90.16±2.44 
2 85.59 89.16 82.82 81. 74 83.66 84.59±2.92 
3 78.81 80.31 79.09 76.52 79.08 78.76±1.38 
4 74.58 76. 77 69.36 73.70 . 72. 77 74.05±2.96 
5 67.58 68.14 62.11 68.04 70.15 67.20±3.01 
6 64.41 66.15 59.00 65.57 61.00 63.23±3.09 
7 59174 60.40 55.90 57.39 57.30 58 .15±1.87 
8 56.57 56.42 50.31 53 .. 26 53.59 54.01±2.62 
9 52.33 51. 77 48.45 49.57 50.54 50. 53±1. 58 
10 48.31 48.45 44.72 46.09 47.06 46. 93±1. 57 
12 42.37 38.50 38. 72 41.96 39.87 40. 28±1.80 
14 36.87 32.96 31.47 36.74 34.42 34.49±2.36 
i6 31. 99 31.64 26.29 28.48 28.76 29.43±2.38 
18 27.97 24.78 21.53 25.87 23.31 24. 69±1. 72 
20 23.73 21. 90 19.88 24.36 20.26 22.03±2.01 
25 15.89 14.82 13.46 13.26 12.64 14.01±1.32 
30 11.02 12.61 8.70 7.17 7.84 9.47±2.28 
40 6.58 3.54 4.14 2.39 1.96 3. 73±1.82 
50 2.54 1.11 1.66 1. 77*±0. 72 
60 1.48 3.76 1. 24 2 .1€1'±1. 39 
*Based on Runs 1-3 
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Since there is a continual decrease in drug concentration in the 
external donor phase and no discernable a phase, it seems likely that 
this phenomena of surface alteration would occur at the liquid 
membrane/internal aqueous phase interface. It may further be 
speculated that the micro rate constant of the apparent 8 phase con-
trolling the transport of solute out of the internal aqueous phase 
may become greater as the concentration of solute increases, thus 
resulting in an overall decrease in the apparent 8 rate. If in fact 
membrane surface alteration is occurring, surfactant would be 
displaced from the interface and possibly form micelles. If this were 
the case, solute may become trapped in the micelle or the transport of 
solute may be otherwise affected by the presence of micelles. 
Another possible reason for displacement of surfactant may be due 
to the limited capacity of the internal aqueous phase droplets. As 
more solute tries to enter these droplets, capacity limitations may 
be exceeded thereby forcing rearrangement in the packing of the sur-
factant molecules and an alterat i on in the permeability of the membrane. 
However, it will be appreciated that the above discussion is in the 
realm of reasonable speculation rather than firm conclusions. 
2. Salicylic Acid 
Four donor solutions, each with a different initial molar 
concentration of salicylic acid (2.5 mM; 4.1 mM; 5.6 mM; 7.2 mM) were 
studied for affect of concentration on solute uptake. Figure 9 
shows the mean apparent ~ rate constants for each se ~ of uptake runs 
as a function of molar concentration. These are listed in Table XV. 
( 
( 
l 
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The rate of uptake at 2. 5 mM \vas very rapid with 1 ess than one percent 
of the drug remaining in the external donor phase after three minutes. 
Sampling every 30 seconds over the three minutes allowed the acquisi-
tion of more data points enabling calculation of an apparent 8 rate 
constant. Although this was a single run and the lim·itations associated 
with assigning sampling times were recognized, two additional runs 
shm~dapproximately the same percent of drug remaining after one minute 
in the external donor phase (21.28%; 22.14%, 25.00%). 
The same trend of decreasing apparent 8 with increased donor 
concentration over a wider range was observed for the uptake of 
salicylic acid as was noted for acetysalicylic acid. Thus in summary, 
the results for these two solutes do indicate that as the initial 
concentration of the drug in the donor phase increases, the apparent 
8 does have a tendency to decrease. 
TABLE XIII 
APPARENT 8 RATE CONSTANTS FOR EACH REPLICATE RUNS OF 
ACETYLSALICYLIC ACID 1.0 g/l UPTAKE. 
Run· Apparent 8 Rate Constant x 10-2 (min-1) 
1 5.88 
2 5.75 
3 5.98 
4 7.11 
5 \ 5.22 
6 5.51 
Mean 5:91 
( 
Run 
1 
2 
3 
4 
5 
TABLE XIV 
APPARENT 8 RATE CONSTANTS FOR EACH REPLICATE RUN 
OF ACETYLSALICYLIC ACID 0.5 g/l UPTAKE. 
Apparent 8 Rate Constant x 10-2 (min-1) 
Mean 
7.06 
8.56 
7.97 
8.90 
9.24 
8.34 
TABLE XV 
MEAN APPARENT 8 RATE CONSTANTS FOR UPTAKE OF VARIOUS 
MOLAR CONCENTRATIONS OF SALICYLIC ACID 
75 
Molar Concentration (mM) Mean Apparent 8 Rate Constant x 10-2 (min-~ 
2.5 
4.1 
5.6 
7.2 
* Number of Runs 
96.11 (1)* 
74.89 (2) 
44. 09 (1) 
49.67 (2) 
D. Effect of Liquid Membrane Oil/Water Ratio on the Rate of Salicylic 
Acid Uptake 
Extraction curves in Figure 10 show the effect of liquid membrane 
oil/water ratio on t he rate of uptake of salicylic acid 1.0 g/1. The 
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( 
mean apparent a rate constants for these uptake processes are 
tabulated in Table XVI. A plot of the mean apparen t a rate versus 
liquid membrane oil/water rat io is presented in Figure 11. As the 
oil/water ratio increased, the drug was extracted le ss rapidly with 
the exception of the 3:1 liquid membrane. In this case a variation 
in the apparent a rate constant was observed and thisapparent a rate 
was greater than that of the 2:1 iiquid membrane. 
78 
It is hypothesized that the oil phase acts as "resistance" in the 
transport process. As the volume or the thickness of the liquid 
membrane increased, the apparent ~ rate constant consequently reduced, 
as would be expected from a consideration of Fick 1 s law (Equation (2)). 
However, it is appreciated that other factors such as variability in 
the mean droplet size of the internal aqueous phase could conceivably 
be responsible for the reduced rate constant. It is quite possible 
that factors which modify the properties of one interface wil l not 
alter the properties of the other. Whereas the external aqueous phase 
was constantly stirred throughout the experi mental ru n, the internal 
aqueous phase was not. It is possible that the internal aqueous phase 
had changed with the formation of larger size droplets which were not 
broken up by agitation. This would result in a decrease in surface 
area at the liquid membrane/internal aqueous phase interface available 
for diffusion and thus a reduced apparent a. 
( 
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TABLE XVI 
MEAN APPARENT S RATE CONSTANTS FOR THE UPTAKE OF SALICYLIC ACID 1.0 g/l 
BY LIQUID MEMBRANES WI TH VARIOUS OIL/WATER RATIOS 
Oil /Water Ratio 
0.5 
0.67 
1.0 
2.0 
3.0 
*Number of Runs 
Mean Apparent S Rate Constant x 
64.98 (2)* 
48. 75 (2) 
49.67 (2) 
18.33 (2) 
33.10 (2) 
E. Effect of Donor Phase pH on the Rate of Solute Uptake 
1. Acetylsalicylic Acid 
10-2 (min-1) 
The effect of donor phase pH on the rate of acetylsalicylic acid 
uptake was investigated using three different pH donor solut ions 
(pH 1, pH 2, pH 3). Figure 12 shows a plot of mean apparent S as a 
function of pH. This mean apparent S rate constants are listed in 
Table XVII. For acetylsalicylic acid, since at low pH more drug exists 
in its unionized form than at high pH, it was expected that the 
apparent S would decrease with increased pH. In fact, however, the 
apparent S rate constant increased and then decreased with a change 
in pH from 1 to 2 differing from that which was expected. 
A more extensive study of acetysalicyl i c acid uptake as a 
function of pH is necessary before any definite conclus ions may be 
drawn. 
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TABLE XVII 
MEAN APPARENT B RATE CONSTANTS FOR THE UPTAKE OF ACETYSALICYL{C 
ACID 1.0 g/l UPTAKE AS A FUNCTION OF DONOR PHASE pH. 
pH 
1 
2 
3 
* Number of Runs 
2. Salicylic Acid 
Mean Apparent s Rate Constant x 10-2 (min-1) 
5.91 (6)* 
7.92 (2) 
5 . 52 (2) 
The effect of donor solution pH on the rate of salicylic acid 
1.0 g/l uptake is shown in Figure 13. The mean apoarent B rate 
. . 
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constants were calculated and are listed in Table ~VITI. A plot of mean 
B as a function of pH (Figure 14) shows that as the pH of the donor 
phase increased, the rate of drug was extracted at a slower rate. This 
result was expected since at lower pH (below 2.97, the pKa for 
salicylic acid), more unionized drug was present in the external donor 
phase for removal in accordance with the pH-partition theory. Using 
the Henderson-Hasselbach equation (Equation 4), it was possible to 
calculate the percent of unionized drug in the donor phase for any pH 
at time 0 (see Table XVIIIl 
An attempt was made to predict the rate of salicylic acid 1.0 g/l 
uptake from donor solutions of various pH us i ng the Hendersor.-
Has~el bach equation and the S/360 Continuous System Modeling 
Program (CSMP). CSMP is 11 ••• a problem-oriented program designed 
to facilitate the digital simulation of a continuous process ... 11 (64). 
( 
( 
The simple model used to describe drug uptake a~pears to be 
insufficient when used in conjunction with CSMP to predict drug 
uptake as a function of pH in a quantitative manner. 
One probable explanation for the failure of the simple model 
83 
and CSMP to quantitatively predict the rate of drug uptake is the 
fact that the surfactant used in the preparation of these emulsions 
contains an amino functional group. At low pH these groups will be 
largely ionized, whereas at higher pH they will be predominately 
unionized. Ionization of the amino functional groups will tend to 
cause mutua1 repulsion of the head groups as well as alter the 
effective HLB of the system. This head group repulsion is likely to 
reduce the packing density of the surfactant molecules in the con-
densed film on both interfaces. This difference in the density of 
the condensed film of surfactant is highly likely to affect the 
interfacial f i lm permeability and also there will be a change in the 
total net charge of the interfacial head groups. 
Further, for any surfactant system with a finite amount of 
surfactant present, reduction in the amount of surfactant present at 
the interfaces must, of necessitys increase the 1 amount of surfactant 
present in either the oil or wa~er phase as monomeric or micellar 
species. Although it is interesting to speculate how the above 
changes could modify the drug membrane transport, the re are so many 
possibilities that at present it would be invalid to draw any con-
clusions. For example, it has already been established that the bulk 
diffusion coefficient of drugs can be both increased and decreased 
( 
( 
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by t he presence of surfactan s. It is noteworthy in t hi s respect that 
certain other workers using l i quid membranes have em;;l yed "mobile" 
surfactants as carriers t c improve transport acro ss li qui d membranes (14). 
pH 
1 
2 
TABLE XVII I 
MEAN APPARENT S RATE CONSTANTS FOR THE UPTAKE Or SALI LY LIC 
ACID 1.0 g/l AS A FUNCTION OF pH. 
Percent Unionized 
at Time 0 
98.93 
89.28 
Mean Apparent S Rate Constant x 10-2 (min-1) 
81.48 (2)* 
54.64 (2) 
3.5 13.83 13.83 (2) 
6 0.01 0.59 (2) 
* Number of Runs 
F. Effect of Viscosity on the Rate of Salicylic Acid Uptake 
As was expected, a slower rate of salicylic acid 1.0 g/l uptake was 
observed as the viscosity of the liquid membrane increased. Mean 
apparent s rate constants were calculated and can be found in Table XIX. 
A plot of salicylic acid as a function of liquid membrane viscosity 
is shown in Figure 15. Since the change in viscosity of each liquid 
membrane results from using oils with different viscosities, it is 
probable that the change in the apparent s rate is directly attributed 
to the diffusiVitY ability of the solute. This may be applied to Fick's 
law (Equation 2). A larger diffusion coefficient will result in a 
faster rate of transport. 
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TABLE XIX 
MEAN APPARENT e RATE CONSTANTS FOR THE UPTAKE OF SALICYLIC 
ACID 1.0 g/l AS A FUNCTION OF LIQUID MEMBRANE VISCOSITY 
87 
Viscosity (cps) Mean Apparent e Rate Constants x l0-2 (min-1) 
3.6 
9.9 
12.8 
21.6 
* Number of Runs 
G. Effect of Temperature on Solute Uptake 
1. Salicylic Acid 
49.67 (2)* 
46.63 (2) 
31.17 (2) 
10.00 (2) 
The effect of temperature on the rate of salicylic acid uptake 
was studied at 4, 16, 28, 37.5, and 50°C. A plot of percent drug 
uptake versus time is shown i n Figure 16. Table XX lists the mean 
apparent e rate constants. As expected, the results show that as the 
temperature increased, the apparent s rate constants for the process 
increased. Due to the extremely rapid removal of drug at 50°C 
(approximately 94% of the total drug was removed in one minute), an 
insufficient number of data points prevented calculation of a rate 
constant. The h·i gh temperature also had an effect on the integrity of 
the liquid membrane. By extending the time of one run at 50°C to five 
hours, the steady leakage of removed drug back out of the liquid 
membrane into the external aqueous phase was observed (Figure 17). 
The high temperature had imposed an abnormal stress on the system 
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89 
which probably caused an alteration in the physical properties of the 
emulsion. The interfacial barrier was altered partially thereby 
permitting removed drug to diffuse out of the internal aqueous phase. 
More discussion of this will follow in a later section concerning the 
subsequent uptake of solutes. 
A semilog plot of mean apparent s rate constant as a function of 
the reciprocal absolute temperature was generated to characterize the 
effect of temperature on the uptake of salicylic acid over the range 
of 4-37°C {Figure 18). An apparent linear relationship between the 
log of the mean apparent S rate constant and reciprocal temperature 
was found to exist (r2 = 0.999, 4 points). The apparent activation 
energy of 8.95 kcal/mole or 3.74 x 104 Joules/mole was calculated from 
the slope of the line obtained. This is a reasonable value for a 
diffusion controlled process. 
The Arrhenius relationship was apparently obeyed as indicated, but 
this does not necessarily mean that the Ea calculated was the true Ea. 
Since, as previously discussed, alterations in the temperature of the 
liquid membrane system not only affect the solute per se but also 
affectsthe properties of the liquid membrane, it is unlikely that the 
transport process is occurring between the same standard states. 
TABLE XX 
MEAN APPARENT S RATE CONSTANTS FOR THE UPTAKE OF 
SALICYLIC ACID 1.0 g/l AS A FUNCTION OF TEMPERATURE 
90 
Temperature °C Mean Apparent s Rate Constants x 10-2(min-1) 
4 
16 
28 
37.5 
50 
*Number of Runs 
10.98 (2)* 
20.51 (2) 
39.95 (2) 
63.45 (2) 
--- ** 
**Approximately 6% of drug remained in external aqueous phase after 
1 minute. 
2. Phenobarbital 
The effect of temperature over the range of 4-45°C on the removal 
of phenobarbital from the external donor phase was investigated. A 
semilog plot of removal of drug as a function of time over the 
temperature range is shown in Figure 19. The a and s rate constants 
were calculated and are listed in Table XXI. The effect of tempera-
ture on these systems was not as expected. As the temperature was 
increased, the a rate constant increased over the range of 4-41°C. 
After reaching a maximum at 41°C, the a rate constant was then reduced. 
Essentially the same phenomena occurred with the B rate constant. 
~~ is rate constant increased with increasing temperature up to 41°C, 
but decreased with any rise in temperature thereafter. 
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The plots of the log k for both a and B versus the reciprocal 
absolute temperature show that the effect of temperature on the rate 
constants cannot be described by the Arrhenius equation (Figures 20 
and 21). 
There are several possible explanations as to why this behavior 
was observed. As indicated by the uptake of salicylic acid at 50°C, 
94 
it appears as though increasing the temperature alters the physical 
properties of the emulsion in such a way as to change the character-
istics of the interfaces. Although, as has been predicted, emulsion 
properties wi 11 change with increasing temperatur·e, the data shows that 
there is a small temperature change at which there is a radical change 
in the ability of the liquid membrane to trap drug. It is suspected 
that this critical temperature (43°C) reflects a substantial disruption 
of one or both interfaces. At all temperatures a steady uptake of 
drug into the liquid membrane was noted. This process occurred at a 
faster rate than the t~ansport of drug from the liquid membrane into 
the internal aqueous phase since a was always greater than a. There-
fore, the ability of the liquid membrane to remove solute at any 
temperature was maintained. 
Another consideration may be the formation of a specific complex 
between phenobarbital and the surfactant depending on the temperature 
sensitivity of the complexation and membrane transport process. This 
could possibly be a factor involved in the type of data reported 
here. 
( 
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TABLE XXI 
MEAN RATE CONSTANTS FOR THE UPTAKE OF PHENOBARBITAL 
0.6 g/l AS A FUNCTION OF TEMPERATURE 
Mean Rate Constants x 10-2 (min-1) 
Temperature oc CL ~ 
4 0.77 8.56 (2)* 
20 1.68 11.01 (2) 
37.5 5.19 12.94 (2) 
41 7.19 59.95 (2) 
42 5.28 44.88 (2) 
43 4. 56 15.70 (4) 
45 0.99 13.42 (2) 
*Number of runs 
H. Effect of Viscosity on the Rate of Phenobarbital Uptake at a 
Critical Temperature 
At room temperature it is expected that as the viscosity of the 
liquid membranes increases, there is a decrease in the rate of drug 
removal from an external aqueous phase. If a faster rate of uptake 
is desired, a liquid membrane of lower viscosity is selected for drug 
removal. It has been demonstrated that at elevated temperatures a 
point was reached in the removal of phenobarbital from the external 
donor phase where the rate constant dramatically decreased instead of 
increased. The temperature range at which this occurred has been 
described as the critical temperature. It was suggested that the 
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critical temperature represents a point where temperature stress is 
such that membrane rupture was beginning or about to occur. 
Since increasing the viscosity of the liquid membrane would likely 
have a stabilizing effect, it seems possible that at the critical 
temperature it would be advantageous to use a liquid membrane with a 
greater viscosity. However, the data presented in Table XXII and 
Figure 22 shows that even at the critical temperature a lower viscosity 
system had greater a and 8 rate constants than a higher viscosity 
system. There was no obvious relationship between viscosity and the 
rate constants. This is not 5urprising since viscosity may itself be 
dependent upon a critical temperature. 
TABLE XXII 
MEAN RATE CONSTANTS FOR THE UPTAKE OF PHEiWBARBITAL 
0.6 g/l AS A FUNCTION OF VISCOSITY AT A CRITICAL TEMPERATURE 
Viscosity (cps) Mean a Rate Constant x 10-2 {min-1} 
3.0 29.56 
9.9 18.88 
12.8 11.20 
21.6 12.46 
*Number of Runs 
I. Evaluation of Liquid Membrane Reuse 
1. Back Transport of Solutes 
Mean 8 Rate Constant 
x 10-2 ~min-1} 
4.56 (2)* 
3.82 
1.17 
3.04 
For most of the experiments in this project the uptake of drug from 
an external aqueous phase was monitored. In this section the back 
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transport or transport of solute from within ~~e liquid membrane 
to the external aqueous phase was investigated. 
Table XXIII lists the estimated as remaining mean percentage 
101 
of drug in the external aqueous phase following exposure to the liquid 
membrane for 120 minutes. According to the pH-partition theory, the 
unionized species transports easily compared to the ionized species. 
At low pH, salicylic and acetylsalicylic acids are predominately 
unionized and therefore available for transport across the liquid 
membrane into the internal aqueous phase. Once inside this internal 
phase the drug is trapped by conversion to its ionized species. If, 
as might well be expected, the ionized species of the solute is 
unable to cross the hydrophobic area of the liquid membrane, then 
transport will not be possible. The data shown in Table XXIII that 
with acetylsalicylic and salicylic acids this was the case when the 
11 new 11 external aqueous phase had a pH of 10. The experimental data 
demonstrated no detectable back transport. 
In the case of phenobarbital, back transport experiments were 
conducted with 11 new 11 external aqueous phases having a pH of either 2 
or 10. When the pH was 2, no back transport was detected. However, 
when the pH of the 11 new 11 external aqueous phase was 10, a significant 
amount of back transport was observed (see Table XXIII). Lack of back 
transport at pH 2 for phenobarbital can be readily explained by the 
fact that at pH 2 this drug is predominately unionized and since it is 
in low competition with the ionized species, the driving force for back 
transport will be low. At pH 10 phenobarbital is predominately in an 
( 
( 
( 
ionized form. Therefore, there is small but finite quantity of 
unionized species which could be available for back transport. This 
seems to be unlikely since the unionized species is present in a 
very low concentration. It is possible that ionized phenobarbital 
had undergone back transport. 
It is noteworthy that Chilamkurti and Rhodes (18) in their 
analysis of micro rate constants for liquid membrane transport 
reached the conclusion that the benzoate ion can cross the liquid 
membrane whereas the salicylate ion cannot. The data presented here 
for salicylic acid confirms the findings of Chilamkurti and Rhodes 
using a different approach (back transport versus analysis of micro 
rate constants). 
TABLE XXIII 
ESTIMATED MEAN PERCENT OF DRUG REMAINING IN THE EXTERNAL AQUEOUS 
PHASE FOLLOWING EXPOSURE TO LIQUID MEMBRANE FOR 120 MINUTES 
102 
Drug 
Mean Percent Remaining 
in pH 10 External 
Aqueous Phase 
Mean Percent Remaining 
in pH 2 External 
Aqueous Phase 
Control (no drug) 
Acetylsalicylic acid 
Salicylic Acid 
Phenobarbital 
2. Subsequent Solute Uptake 
0.0 
0.0 
0.0 
13:0 0.0 
The ability of liquid membranes to remove one solute from an 
external aqueous phase following the removal of another solute was 
( 
( 
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investigated for three systems. In each case it was observed that the 
liquid membrane was capable of subsequent uptake of drug to varying 
degrees. Figures 23, 24, and 25 show the extraction curves for the 
removal of the second drug. 
In the first system the uptake of phenobarbital following the 
removal of salicylic acid at 50°C was slow but steady for one run 
(Figure 23). When this was repeated, the uptake was slow and variable 
as a function of time (Figure 23). Variability in this data is 
somewhat disappointing but not entirely unexpected. As reported in this 
thesis, the extraction curves for one component system are very 
reproducible and very much better than might be expected for a complex 
dispersed system. However, whenever one tries to study the extraction 
of a second solute when the system has already been perturbed by the 
extraction of a compound, nonreproducible results may be obtained. 
It is very easy to postulate that such factors as mean liquid membrane 
thickness or interfacial area may be substantially modified. Based on 
the previous findings regarding salicylic acid in single component 
uptake at 50°C, it is possible that the diffusion of salicylic acid 
into the external aqueous phase may be the result of some alteration 
in the penneability of the liquid membrane due to the high temperature 
(Figure 26). This indicates membrane rupture and not transport of 
ionized solute. Moreover it is also noteworthy that whereas salicylic 
acid trapped in the internal aqueous phase did not diffuse out when the 
pH of a 11 new 11 external aqueous phase was increased, in the present 
system salicylic acid diffused into the external aqueous phase when the 
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pH was low. This further indicates membrane ruptcMe had occurred 
and not transport of the ionized species. 
TABLE XXIV 
MEAN APPARENT B RATE CONSTANTS FOR THE UPTAKE OF 
SALICYLIC ACID 1.0 g/l FOLLOWiNG PHENOBARBITAL UPTAKE 
108 
System Mean Apparent B Rate Constant x 10-2 (min-1) 
I 37.5°C 
II 45°C 
*Number of Runs. 
41.48 (2)* 
40.24 (1) 
A simiiar trend was observed for the second and third systems 
studied. In these systems the removal of salicylic acid from the 
external aqueous phase subsequent to phenobarbital remova~ was in-
vestigated at 37.5 and 4s:c. Under both conditions the removal of 
salicylic acid was steady and essentially complete (Figures 24 and 25). 
The mean apparent B rate constant calculated for these systems are 
listed in Table XXIV. As can be seen, the range of B values varied 
widely for uptake at 37.5°C (22.64 x 10-2 (min-1) and 50.18 x 10-2 
(min-1)). These B values were also less than the apparent mean B rate 
constant calculated for the uptake of salicylic acid in a single 
component system (22.64 x 10-2 (min-1) and 50.18 x 10-2 (min-1) versus 
63.45 x 10-2 (min-1). Figure 27 shows the appearance of phenobarbital 
in the external aqueous phase as a function of time for one run at 
37.5°C. 
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J. Evaluation of Co-Uptake of Solutes from One Donor Solution 
1. Co-Uptake of Solutes with Different Initial Molar 
Concentrations 
Table XXV lists the mean apparent rate constants for the co-uptake 
of two drugs from one donor phase when their init i al molar concentra-
tions were different. As can be seen from these results, the liquid 
membrane was capable of the simultaneous uptake of drugs. The 
apparent rate constants and extent of drug uptake differed for each 
drug in solution with another drug. The mean percent of each drug 
remaining in the external aqueous phase at 120 minutes can be found 
in Table XXVI. 
From Table XXVI it can be shown that essentially complete uptake 
had occurred by the end of the experimental run for acetylsalicylic 
and salicylic acid in a donor phase containing both solutes. However, 
25.24% and 33.78% of the initial total of phenobarbital remained in 
the external aqueous phase when th i s drug was removed from a solvent 
which also conta i ned acetylsalicylic and salicylic acids respectively. 
The highest apparent rate constants were calculated for salicylic 
acid in a solvent which contained either acetysalicylic acid or 
phenobarbital. Although the mean apparent e rate constant describing 
the uptake of salicylic acid from a multicomponent external aqueous 
phase containing acetylsalicylic acid was less than that for salicylic 
acid in a single component syste~ (32.27 x 10-2 (min-1) versus 
49.67 x 10-2 (min-1)), the mean apparent s rate constant for salicylic 
acid in an external aqueous phase with phenobarbital was greater 
( 
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(59.79 x 10-2 (rrin-1) versus 49.67 x 10-2 (min-1)). Additional data 
would be useful in deten~ining the statistical significance of the 
differences in these rate constants. Although these differences 
appear to be small, they may be statistically as well as therapeuti-
cally significant. 
A possible explanation for fonner case described above may be 
based on the similarity in chemical structure of acetysalicylic and 
salicylic acids. As previously observed for both of the drugs in 
single component systems, increasing the initial concentration of drug 
in the external aqueous phase resulted in a decreased apparent s rate 
constant. It was speculated that increasing the initial concentration 
resulted in an alteration of the surfactant properties at the liquid 
membrane/internal aqueous phase interface. It was further speculated 
the internal aqueous phase droplets became larger with decreased 
surface area resulting. 
In the case of co-uptake of acetysalicylic and salicylic acids, this 
mixture of drugs in one donor phase may have had the same effect as 
increasing the concentration of one of these drugs alone in the 
external donor phase. Thus, the decrease in the apparent s rate 
constant was observed for salicylic acid. 
The increased mean apparent s rate constant for salicylic acid in 
the presence of phenobarbital may possibly be a result of an inter-
action between phenobarbital and the surfactant at both interfaces to 
produce an alteration in the properties of the liquid membrane. This 
could favor the transport of salicylic acid into both the liquid 
( 
( 
membrane and the internal donor phase. In addition thi ~ alteration 
may increase the micro rate constant controlling the transport of 
salicylic acid into the liquid membrane with an increase in the 
apparent 8 rate constant for the system resulting. 
It is interesting to note that essentially the same phenomena 
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occurred with the co-uptake of acetylsalicylic acid and phenobarbital. 
The mean apparent 8 rate constant for acetylsalicylic acid was less 
when it was in a multicomponent donor phase with salicylic acid than 
with phenobarbital (6.74 x 10-2 (min-1) verus 11.41 x 10-2 (min-1)). 
The apparent 8 rate constant for phenobarbital in a multicomponent 
system wi th acetylsalicylic acid was similar to that obtained for 
phenobarbital in a co-uptake situation with salicylic acid (1.24 x 
10-2 (min-1) versus 1.25 x 10-2 (min-1)) . 
TABLE XXV 
MEAN APPARENT RATE CONSTANTS FOR THE CO-UPTAKE OF DRUG I IN A MULTI-
COMPONENT SYSTEM WITH DRUG II WHEN INITIAL MOLAR CONCENTRATIONS 
ARE DIFFERENT 
Drug I 
Acetylsalicylic 
Acid 5. 6 mM 
Salicylic Acid 
7.2 mM 
Phenobarbital 
2.5 mM 
Drug II 
Acetylsalicylic 
Acid 5~6 - mM 
32.27 (8) 
6.65 (a) 
1.24 ( S) 
(one run) 
Salicylic 
Acid 7.2 mM 
6.75 ( 8) 
1.25 (8) 
Phenobarbital 
2.5 mM 
11.41 (8) 
59.79 (8) 
( 
( 
TABLE XXVI 
MEAN PERCENT OF DRUG I REMAINING IN THE EXTERNAL AQUEOUS 
PHASE AT 120 MINUTES AFTER ·CO-UPTAKE WITH DRUG II 
Drug I Drug II Mean Percent Drug I 
Acetylsalicylic Acid 1. Phenobarbital 1. <l.00 
2. Salicylic Acid 2. <1.00 
Salicylic Acid 1. Phenobarbita 1 1. <1.00 
2. Acetylsalicylic 2. <l.00 
Acid 
Phenobarbital 1. Sal i cylic Acid 1. 33.78 
2. Acetylsalicylic 2. 25.24* 
Ac i d 
*One Run. 
2. Co-Uptake of Solutes with Equimolar Initial Concentrations 
The effect of concentration on co-uptake was further studied 
by exposing liquid membrane to an external donor phase containing 
equimolar concentrations of two solutes. System I consisted of 
equimolar concentrations of salicylic and acetylsalicylic acids 
113 
(5.6 mM) while System II contained salicylic acid and phenobarbital 
at 2.5 mM concentrations. Table XXVII l i sts the mean apparent e rate 
constants for each drug and the mean percent of drug remaining in the 
external aqueous phase after 120 minutes. 
In System I both acetylsalicylic and salicylic acid were essentially 
completely removed from the external donor phase after 120 minutes. 
The mean apparent e rate constant for salicylic acid in this system 
was approximately equal to the rate constant for this drug when 
alone in the external donor phase (49.10 x 10-2 (min-1) versus 
Sy stew 
I 
II 
,...--,.. 
TABLE XXVII 
MEAN APPARENTB RATE CONSTANTS FOR THE CO-UPTAKE OF SOLUTES IN EQUIMOLAR 
INITIAL CONCENTRATIONS IN A MULTICOMPONENT SYSTEM AND MEAN PERCENT 
REMAINING IN THE EXTERNAL .AQUEOUS PHASE AT 120 MINUTES 
Solutes and Molar 
Concentration (mM) 
Salicylic Acid 5.6 
Acetylsalicylic Acid 5.6 
Salicylic Acid 
Phenobarbital 
2.5 
2.5 
Mean Apparent B Rate 
Constant x 10-2 (min-1) 
49.10 (2)* 
6.95 (2) 
- --** 
3.41 (2) 
Mean Percent Remaining 
in External Aqueous 
Phase at 120 Minutes 
< 1.00 
< 1. 00 
< 1.00 
9.48 
•·Number of Runs. 
**Too rapid to calculate. 
' 
-+::> 
( 
115 
49.67 x 10-2 (min-1)). This rate constant was greater than t~at for 
salicylic acid in a non-equimolar multicomponent system with acetyl-
salicylic acid (49.10 x 10-2 (min-1) versus 32.27 x 10-2 (min-1)). 
Moreover the mean apparent s rate constant for acetylsalicylic acid in 
System I was approximately· the same as that calculated for this drug 
in a non-equimolar ~ulticomponent system with salicylic acid (6.95 x 
10-2 (min-1) versus 6.74 x 10-2 (min-1)). 
The total molar concentration of solute in the external donor 
phase with these two drugs in equimclar concentrations was less than 
the total molar concentration of solute in the previous co-uptake 
system of these two drugs (11.2 mM versus 12.8 mM of solute). As 
previously observed for these two solutes as single component systems, 
a decrease in concentration resulted in increased mean apparent s rate 
constants. The mean apparent s rate constants obtained for the present 
system seem to support the proposed speculations of membrane surface 
property alterations and changes in the size of the internal aqueous 
phase droplets. At this lower concentration alterations in the 
properties of the membrane are not as great as the more concentrated 
system and the internal aqueous phase droplets were not exposed to as 
much solute. This resulted in increased apparent s rate constants. 
For System II the rate of .salicylic acid uptake was too rapid to 
calculate a rate constant for the process. After two minutes less than 
one percent of the drug remained in the external donor phase. This 
rapid removal of salicylic acid was similar to both the removal of this 
drug from a single component 2.5 mM system and from the previous 
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salicylic acid/phenobarbital co-uptake system. The percent of 
phenobarbital remaining in the external aqueous phase after 120 minutes 
decreased as compared with the percent remaining in the previous 
salicylic acid/phenobarbital co-uptake system (9.48 versus 33.78). 
In a co-uptake system, the rate constant and percent of 
phenobarbital remaining in the external aqueous phase appears to be 
affected by the total solute concentration in the donor phase. 
Speculation regarding the mechanisms involved as discussed previously 
with phenobarbital/salicylate uptake may be applied to this system. 
The effect of phenobarbital appears to be insignificant to the uptake 
of salicylic acid at these lower solute concentrations of the external 
aqueous phase. It is also possible that the lower concentration of 
solute in the external aqueous phase enhanced the phenobarbital uptake 
in the same manner. 
Because of a short supply of liquid membrane, the combinations of 
solutes for co-uptake was limited. For this reason the interpretation 
of the data described above must of necessity be somewhat speculative. 
Although differences were noted through the comparison of some apparent 
e rate constants, additional data would aid in determining if these 
differences were significant. From a practical point of view these 
changes in the apparent e rate constants may not be of such a 
magnitude as to be significant. 
3. Effect of Liquid Membrane Oil/Water Ratio on the Co-Uptake of 
Solutes 
In general, the effect of liquid membrane oil/water ratio on the 
co-uptake of phenobarbital (2.5 mM) and salicylic acid (7.2 mM) was as 
( 
l 
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expected. As the ratio of 1il/water increased, the uptake of drug by 
the system was slower. For this situation two parameters must be 
considered--the oil/water ratio of the membrane and the presence of two 
drugs in the external aqueous phase . 
Figure 28 shows that the mean apparent s rate constant decreased 
as a function of increasing oil/water ratio for the uptake of pheno-
barbital as expected. Table XXVIII lists the mean apparent s rate 
constants for this process. As discussed in a previous section, 
membrane thickness would be expected to decrease the rate of drug 
transport. 
TABLE XXVIII 
MEAN APPARENT S RATE CONSTANTS FOR THE CO-UPTAKE OF DRUGS AS 
A FUNCTION OF LIQUID MEMBRANE OIL/WATER RATIO 
Drug Oil/Water Mean Apparent S Rate Constant Ratio x 10-2 (min-1) and Range 
Salicylic Acid 0.5 48.86 ( 2)* 44.56-53.16 
0.67 54.89 (2) 49.82-59.95 
1.0 59.79 (2) 55.19-64.38 
2.0 32.98 (2) 30.85-35.10 
3.0 26.99 (2) 26.98-27.01 
Phenobarbital 0.5 2.28 (2) 2.14-2.41 
0.67 1 .. 95 (2) 1.92-1.98 
1.0 1.25 (2) 1.03-1.48 
2.0 1.01 (2) 0.88-1.13 
.3.0 0.72 (2) 0.70-0.74 
*Number of Runs 
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As can be seen from Table XXVIII, there appears t o be an optimum 
oil/water ratio (1.0) for the uptake of salicylic acid from the 
multicomponent system. As a general trend, the higher oil/water ratios 
gave a lower s rate constant. However, the range of apparent s rate 
constants varied widely at the lower oil/water ratios. Therefore, it 
was difficult to designate a specific order of decreasing apparent s 
rate constants for these three liquid membranes (O.S; 0.67; 1.0). 
Additional studies at the lower oil/water ratios may help to clarify 
the order of rate constants in this situation. 
Based on the previous results of co-uptake of phenobarbital and 
salicylic acid at one oil/water ratio (1.0), it was expected salicylic 
acid would behave similarly when the oil/water ratio was varied. In 
general this was the case. 
K. Effect of Freeze/Thaw on the Use of Liquid Membranes 
The integrity of liquid membranes and their capacity to function 
as sinks was investigated by freezing and thawing three liquid mem-
branes and then exposing them to drug donor solutions. Gross changes 
were observed after thawing. Nearly total phase separation was noted 
but the emulsions could be redispersed with vigorous agitation into a 
homogenous system. Figure 29 shows a plot of percent drug in the 
external aqueous phase versus time for each of the frozen/thawed 
systems. The apparent s rate constants are listed in Table XXIX. 
Surprisingly, these rate constants were almost identical to the mean 
apparent s rate constants for salicylic acid using these membranes 
under ideal conditions (Table· XXIX). It is realized that these rate 
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the external aqueous phase. Some of the emulsions had good physical 
properties and readily dispersed as discrete globules when mixed with 
pH 2 buffer. Their initial flow was average but after standing over-
night the emulsions barely flowed or flowed with great difficulty from 
their containers. These emulsions included 1, 2, 11 and 14 (see 
Tables XXX and XXXI). 
The second major problem, the incomplete dispersion of the emulsion 
as globules in an external donor phase was observed in a number of 
formulations which otherwise had good overall properties. In some 
cases this problem was detected at time O; for other systems this 
became apparent after overnight storage or when mixed in an appropriate 
quantity of pH 2 buffer in the reaction flask. The series of emulsions 
in which this was most prevalent was emulsions 15-19. Slight changes 
in the total percent of emulsifier blend improved the viscosity and 
flow characteristics of the emulsions. When these systems were tested 
for dispersion as globules, they failed to disperse into globules 
when it was mixed with external aqueous phase. 
The formulations which demonstrated the most promise for use in a 
liquid membrane system were 20a, 20b, 21a, and 21b. Emulsion 20a 
creamed after storage overnight but was readily dispersed and used in 
an extraction experiment. The data obtained from an uptake run using 
salicylic acid 1.0 g/l is contained in Table XXXII. Rapid and 
essentially complete drug removal was observed. Si milar results were 
observed when Emulsion 21b was used in an extraction experiment for 
salicylic acid 1.0 g/l. 
( 
( 
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constants were obtained from one set of data, yet it is felt that they 
are indicative of the capacity of the liquid membrane to withstand 
stress. 
TABLE XXIX 
A COMPARISON OF THE APPARENT B RATE CONSTANTS FOR THE UPTAKE OF 
SALICYLIC ACID 1.0 g/1 USING A FREEZE/THAW STRESSED LIQUID MEM-
BRANE VERSUS THE MEAN APPARENT B RATE CONSTANTS FOR THE UPTAKE 
OF SALICYLIC ACID 1.0 g/1 UNDER IDEAL CONDITIONS 
Apparent B Rate Mean Apparent S Rate 
Viscosity Constant x 10-2 (min-1) Constant x 10-2 (min-1) 
Freeze/Thaw Stress Ideal Conditions 
9.9 49.44 (1)* 46.63 (2) 
12.8 31.02 (1) 31.17 (2) 
21.6 12.04 (1) 10.00 (2) 
*Number of Runs. 
L. Evaluation of the Fonnulation Aspects of Liquid Membranes 
1. Evaluation of Emulsions Prepared Using the HLB Approach 
The results of the evaluation of emulsions prepared using the HLB 
approach are listed in Tables XXX and XXXI. In general good stability 
was observed for these systems. Most of the emulsions had good white 
color indicating a small mean particle size. Those emulsions which 
were the whitest tended to be the most stable as would be expected. 
The major problems associated with the use of these emulsions as 
liquid membranes were their high viscosity (i.e. far too thick) and, 
in some instances, their incomplete dispersion as discrete glcbules in 
-,..--._, .-..._ 
TABLE XXX 
VISUAL ANALYSIS, DETERMINATION OF EMULSION TYPE, AND EVALUATION OF POTENTIAL TO FORM 
A LIQUID MEMBRANE FOR THOSE EMULSIONS PREPARED USING THE HLB APPROACH 
The emulsions listed in this table correspond to-those described in Table V. 
Emulsion Time - Hours 0 24 
Potential to Potential to 
Color Separation Type Form a Liquid Color Separation Type Form a Liquid 
Membrane Membrane 
1 ow 0 w/o 1 ow 0 w/o 1 
2 gw +l o/w 0 gw +l o/w 0 
3 ow 0 w/o 1 ow 0 w/o 1 
4 gw +l o/w 0 gw +l o/w 0 
5 ow 0 w/o 1 ow 0 w/o 1 
6 ow +l o/w 0 ow +l o/w 0 
7 ow 0 w/o 1 ow 0 w/o 1 
8 w +1 w/o 0 w +l w/o 0 
9 w 0 w/o 1 w 0 w/o 1 
10 w 0 w/o 1 w 0 w/o 1 
11 gw +l w/o 0 gw +l w/o 0 
12 ow 0 w/o 1 gw 0 w/o 1 
13 ow 0 w/o 1 ow 0 w/o 0 
14 ow 0 w/o 1 ow 0 w/o 1 
N 
w 
,..........., 
TABLE XXX (Continued) 
Emulsion Time - Hours 0 
Potential to 
Color Separation Type Form a Liquid Color 
Membrane 
15 w 0 w/o 1 w 
16 w 0 w/o 1 w 
17 w 0 w/o 1 w 
18 w 0 w/o 1 w 
19 w 0 w/o 1 w 
20a* w 0 w/o 1 w 
b* w 0 w/o 1 w 
21a w 0 w/o 1 w 
b w 0 w/o .1 w 
*Reproducibility difficult 
Key: ow = off white, gw = grayish white, w = white 
o = none, +1 = separation occurred, 1 = good potential 
24 
Separation Type 
0 w/o 
0 w/o 
0 w/o 
0 w/o 
0 w/o 
+l w/o 
0 w/o 
0 w/o 
0 w/o 
Potential to 
Form a Liquid 
Membrane 
1 
0 
0 
0 
0 
1 
1 
1 
0 
N 
~ 
( 
TABLE XXXI 
DETERMINATION OF VISCOSITY AND CHARACTERIZATION OF FLOW 
FOR THOSE EMULSIONS PREPARED USING THE HLB APPROACH 
The emulsions listed in this table correspond to those described in 
Emulsion 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20a 
20b 
2la 
2lb 
0 
Average Viscosity 
(cps) 
3.7 
3.5 
3.27 
2.12 
3.66 
3.45 
3.8 
1.55 
1.37 
1.34 
1.01 
0.92 
1.68 
2.24 
1.92 
2:12 · 
Time - Hours 
Flow 
3 
3 
3 
3 
5 
3 
5 
3 
2 
4 
3 
4 
3 
3 
2 
2 
2 
1 
1 
2 
2 
2 
2 
Average Viscosity (cps) 
2.12 
3.45 
1.55 
1.37 
1.34 
1.03 
0.93 
1.65 
2.26 
1.92 
2.15 
24 
-- Emulsion either too viscous to too unstable to determine 
viscosity. 
Flow 
5 
3 
5 
3 
5 
3 
5 
3 
2 
4 
4 
4 
3 
5 
2 
2 
2 
1 
1 
2 
2 
2 
2 
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TABLE XXXII 
PERCENT SALICYLIC ACID REMAINING IN THE EXTERNAL AQUEOUS 
PHASE WITH TIME AFTER EXPOSURE TO EMULSIONS MANUFACTURED 
USING THE HLB APPROACH 
Time (minutes) 
0 
1 
2 
3 
4 
5 
6 
Percent Salicylic Acid Remaining in ·the 
External Aqueous Phase 
Emulsion 20a Emulsion 21b 
100.00 
8.38 
2.87 
11.09 
0.93 
0.54 
100.00 
18.79 
6.70 
5.47 
4.90 
2.12 
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The major problem with obtaining additional data with these systems 
was difficulty to manufacture reproducible batches. The characteristics 
of Emulsion 20a changed when this emulsion was prepared by homogeniza-
tion. The homogenized version, Emulsion 20b, was too viscous for use 
in a liquid membrane system. Whereas Emulsion 21a was unacceptable 
for forming a liquid membrane system, the homogenized version, 21b, as 
can be seen from the data reported above, was acceptable as a liquid 
membrane. In all cases when the batch size was increased, the results 
were not reproducible. 
The Exxon liquid membranes used in this project have remarkable 
physical stability, as noted by the freeze/thaw stress, but they are 
( 
( 
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not GRAS. It is known that other research groups have been attempting 
to form stable liquid membranes with GRAS ingredients. They have had 
limited success and are far from being marketable products. GRAS 
materials are restricted in the number of components meeting these 
specifications and are subject to aging effects, as was seen in this 
present study. In the final stages of emulsion manufacture, intuitive 
rather than scientific aspects of formulation are important. 
There are several reasons why the emulsions manufactured in this 
project were not acceptable for use as liquid membranes. It is 
believed that the emulsifier blend and method of achieving emulsifica-
tion are two key concerns. Although the HLB approach worked reasonably 
well when used in the formulation of a three rather than two phase 
system, subsequent treatment of these emulsions to create a liquid 
membrane system had an adverse effect on these products. Dispersing 
the emulsions in pH 2 buffer with continued and more vigorous agitation 
seemed to contribute to phase inversion or cracking which rendered the 
emu l sions unacceptable. Achieving the correct delicate balance of 
stabilizers and surfactants is a necessity for the overall stability 
of these emulsions if they are to be used successfully as liquid 
membranes. In this project, although it was possible to manufacture 
a stable w/o emulsion, the formation of a stable w/o/w liquid membrane 
system was difficult. It is possible that the surfactant blend was at 
a critical concentration and this resulted in instability when the 
w/o emulsion was treated further. A change in manufacturing technique 
is a widely accepted reason for changes in emulsion characteristics. 
( 
This was believed to be a proble~ in this study, particularly during 
scale-up operations. 
2. Evaluation of Emulsions Using the Davis Approach 
An attempt was made to reproduce the formula published in the 
literature by Davis (19). Reproducing emulsions from a published 
formula is generally known to be difficult; therefore, it was not 
surprising that this formula could not be reproduced and that the 
emulsions manufactured in this attempt were extremely poor (65). 
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VI. sur ~MARY 
The fol lowing are believed to be the salient poi nt s of t bis work as 
reported and discussed in the previous section . 
The initial concentration of solute in the external dono r phase 
appears to have an effect on the rate constants controlling the 
removal of solutes by liquid membranes. A decreased mean apparent 8 
rate constant was observed for both salicylic and acetylsal i cylic acids 
when the intitial concentration of solute in the external donor phase 
was increased. It was speculated that this may have been the result of 
alterations to the surface properties of the membrane which changed its 
permeability to the solute. Increases in the size of the internal 
aqueous phase droplets resulting in a decrease in surface area at the 
liquid membrane/internal aqueous phase interface was also considered 
as a possible explanation for this phenomena. It should be noted here 
also that decreased apparent 8 rate constants for solutes were observed 
as the total concentration of solute increased in a multicomponent 
system (i . e. two drugs in the external aqueous phase). 
The pH of the external donor phase was observed to affect the rate 
constants describing salicylic acid uptake in the expected manner. At 
low pH the apparent 8 rate constants were greater than at higher pH. 
This was due to more n9ni oni zed drug being ava i 1ab1 e for transport at 
low pH values. An attempt was made to predict quantitat ·ively salicylic 
acid uptake as a function of pH over 60 minutes us i ng a CSMP computer 
( 
program and based on the simple liquid membrane model described 
previously. Lack of quantitative agreement between predicted and 
experimental data is attributed to the complexity of the system and 
insufficiency of the model. Factors such as effect of pH on the sur-
factant and changes in the concentration of micelles may have contri-
buted to the complexity of the model. 
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The study of the effect of temperature on the uptake of solutes by 
liquid membranes revealed some interesting phenomena. Whereas the 
apparent s rate constant controlling salicylic acid uptake increased 
with increases in temperature, as expected, and apparently followed the 
Arrhenius relationship, this was found to be true for phenobarbital 
until a critical temperature was reached. It was discovered that a 
critical temperature range existed above which a sharp decrease in the 
a ands rate constants resulted. It is believed that the liquid 
membrane was beginning or nearly about to collapse. It is speculated 
that changes in the physical properties at this high and critical 
temperature were responsible for this or that secondary reactions 
between the surfactant and phenobarbital resulted in a temperature 
sensitive formation of a complex. Through this complex, it was thought 
that 'changes in the nature of the interfaces resulted in alterations 
in solute permeability. By increasing the viscosity of the liquid 
membrane used at this critical temperature, it was thought that solute 
transport might be improved. This was not found to be the case, in 
fact, there was no obvious relationship between the rate constants 
and viscosity at the critical temperature. Viscosity of the membrane 
I 
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itself may be dependent upon a critical temperature aGd further studies 
in this area may be useful in detennining if this is true. 
Altering the physical properties of the liquid membranes was found 
to have the predicted affects on solute uptake. By increasing the 
oil/water ratio, the rate of solute uptake decreased. This was 
observed for salicylic acid in both single component and multicomponent 
systems and for phenobarbital in a multicomponent system. The increased 
thickness of the oil phase and any possible changes in the amount of 
surface area from the internal aqueous phase droplets are proposed as 
possible explanations for this occurrence. 
As the viscosity of the liquid membrane increased, the rate of 
salicylic acid decreased, as would be expected by consideration of 
Fick's law. It is probable that as the oil was changed to achieve a 
more viscous membrane, the diffusion coefficient of the drug changed, 
hence slower transport. 
Through evaluation of the reuse of liquid membrane, it was seen 
that whereas some drugs (acetylsalicylic and salicylic acids) were not 
capable of back transport (i.e. transport from the liquid membrane to 
the external aqueous phase), phenobarbital was able to transport from 
the liquid membrane into the external aqueous phase. This confinned 
the findings of Chilamkurti and Rhodes, wbo through the analysis of 
the micro rate constants, showed that some ions could indeed transport 
out of the 1 i quid membrane (i.e. tenzoate ... iQn.~,_ wbereas others could not 
..... 
(i.e. salicylate ion). 
The liquid membranes demonstrated the ability to subsequently remove 
one drug following the removal of another. 
( 
( 
The co-uptake of solutes was investigated on two leve1s--
multicomponents systems in which the solutes were not in equimol ar 
concentrations and those in which they were. In all cases co-uptake 
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was achieved but to varying degrees. In general, faster rates of uptake 
were obtained in multicomponent systems of Jower total solute concen-
tration. This was similar to the effect of increasing salicylic or 
acetylsalicylic acid concentrations as single component systems on the 
rate of solute up. The reasons proposed for this phenomena may well be 
applied to multicomponent systems. 
Freeze/thaw stressing of the liquid membranes proved that they are 
very stable systems. The apparent e rate constants obtained from 
experimental runs using these membranes was surprisingly similar to 
-those obtained for uptake under ideal conditions. 
Although the formulation of liquid membranes with GRAS components 
was difficult, some success was achieved with the production of two 
systems which used liquid membranes in drug removal runs. Method of 
manufacture and appropriate surfactant blends were determined to be key 
factors in the development of these systems for use as liquid membranes. 
The HLB approach to emulsion formulation was found to be a useful tool 
in the development of these systems. 
In suwmary, the major impact of the data reported here on the 
theoretical aspects of liquid membrane transport will be on the 
deve1opmentoramodel which will describe this complex process. 
Although in many instances the data obtained could readily be eAplained 
by the simple model proposed by Yang and Rhodes and Chilamkurti and 
( 
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Rhodes, it was insufficient to rationalize all aspects of liquid 
membrane transport when additional parameters were defined and included 
the model. Realizing that this is a complex system, it would be 
inappropriate at this time to develop a model which would quantitatively 
predict all aspects of liquid membrane transport. Clearly, further 
study of the kinetics of more complex liquid membrane systems is a 
fascinating and challenging area for research. 
The results reported in this thesis have relevance for a number of 
practical pharmaceutical applications of liquid membranes. 
Although the attempt to produce liquid membrane formulations using 
GRAS components was only partially successful and it is fully realized 
that none of the formulations developed in this study are such that they 
could be marketed in their present fonn, it is believed that the data 
reported overall tends to strongly support the potential development 
of liquid membranes for phannaceutical uses. Although many of these 
systems were highly viscous, this does not preclude their use for the 
delivery of drug by the vaginal or rectal routes or orally through 
encapsulation in soft gelatin capsules. 
It is generally recognized that phannaceutical emulsions are 
complex, thennodynamically unstable systems very much more difficult to 
manufacture on a larger scale in a reproducible manner than are a 
number of other dosage forms such as compressed tablets. These 
difficulties are compounded in the case of complex emulsions such as 
liquid membrane systems. The successful development of such complex 
dispersed systems for commercial use is at the present time often 
intuitive rather than entirely scientific. 
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For example, the production of IV fat emulsions which would be 
able to tolerate sterilization by autoclaving at 115°C was a thorny 
problem which was finally solved by one company at least, by the chance 
observation that intermittent agitation during the cooling part of the 
sterilization cycle preventsthe occurrence of physical stability 
problems. It seems likely that because of our present incomplete 
understanding of all the factors which govern the properties of liquid 
membrane systems, the corrunercial development of these products may also 
depend upon such a chance observation or intuition. 
Through the study of the effect of _temperature on the uptake of 
phenobarbital and salicylic acid, it was observed that improved rate 
constants controlling solute uptake occur at body temperature. It is 
noteworthy that a critical temperature, 43°C, was discovered in the 
uptake of phenobarbital, a temperature significantly above the usual 
range of body temperature. 
The results obtained from the evaluation of liquid membrane reuse 
demonstrate that under the proper conditions of pH and solute/ 
surfactant interaction, these systems have the potential to act as drug 
delivery systems. More studies on the transport of some ionized 
species out of a liquid membrane may further expand this area of 
research. 
Reuse of liquid membranes in terms of subsequent drug removal may 
have application in the multiabsorption of drugs in overdose situations. 
Another area which has direct application is the use of liquid mem-
branes overdose situations is the co-uptake of solutes. The liquid 
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membranes were found to behave well in the presence of multicomponent 
external aqueous phases. Although changes in the rate of uptake were 
observed in some cases, these changes are thought to have little effect 
on the overa 11 ability of .these membranes to remove two solutes 
simultaneously. 
In conclusion, it is believed that the data reported in this thesis 
are likely to prove valuable in the development of a comprehensive, 
rational theory defining the properties of liquid membrane systems. 
Also it is appreciated that the data reported in this thesis clearly 
defines a number of aspects pertinent to the practical application of 
liquid membranes as drug delivery systems or drug sinks in the 
emergency treatment of .drug overdose. 
( 
VII. CONCLUSIONS 
1. High pressure liquid chromatography was a sensitive, 
reproducible and reliable assay technique for the detection of drug 
in liquid membrane solute uptake experiments. 
2. Viscosity and oil/water ratio of liquid membranes will 
influence the rate of solute uptake. 
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3. It appears that optimum environmental conditions are necessary 
for the efficient removal of solutes by liquid membranes. Whereas 
increasing the temperature will increase the rate of uptake of a solute, 
there appears to be a critical temperature for phenobarbital uptake. 
Increasing the pH and solute concentration of the external aqueous 
phase decreases the rate of solute uptake. 
4. Computer modeling techniques to describe the uptake of solutes 
with liquid membranes were of limited value. This was probably due to 
the complex nature of the system. 
5. Liquid membranes show potential for use in co-uptake and 
multidruguptake and they appear to be reusable. 
6. Freezing liquid membranes does not appear to have any adverse 
affects on the efficiency of these systems to remove solute from an 
external aqueous phase. 
7. The method of manufacture and appropriate surfactant blend 
were determined to be key factors in the development of emulsions for 
use as liquid membranes. 
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